Suppurative and necrotic conditions of lower respiratory tract

J10_NECROTIC

pleural empyema: The presence of pus in the thoracic cavity, between the visceral and parietal pleura. [database_cross_reference: NCIT:P378]

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — J85-J86 Cause of death: ICD-10 — J85-J86 2 out of 7 registries used, show all original rules.	2351
4. Check minimum number of events None	2351
5. Include endpoints J10_LUNGNECROSIS J10_ABSCLUNGPNEUMO J10_ABSCMEDIASTINUM J10_PYOTHORAX	2547
6. Filter based on genotype QC (FinnGen only)	2234

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2

NAME	J10_NECROTIC
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	J10_LUNGNECROSIS\|J10_ABSCLUNGPNEUMO\|J10_ABSCMEDIASTINUM\|J10_PYOTHORAX
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	J8[5-6]
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	J8[5-6]
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Suppurative and necrotic conditions of lower respiratory tract based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	18004	5053	12664
Only index persons	13269	3969	9300
Unadjusted period prevalence (%)
Whole population	0.29	0.14	0.35
Only index persons	0.29	0.15	0.36
Median age at first event (years)
Whole population	60.87	62.52	60.16
Only index persons	60.11	61.41	59.55

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2234	640	1594
Unadjusted period prevalence (%)	0.59	0.23	0.73
Median age at first event (years)	64.32	61.12	65.60

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2323: Matched controls
23230

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

5.1

319.2

1008

3026

J18.9

ICD-10 Finland

Pneumonia, unspecified

7.7

307.7

1574

4961

J86.9

ICD-10 Finland

Pyothorax without fistula

+∞

307.7

1478

GAC97

NOMESCO Finland

Other endoscopic operation on pleura

196.7

307.7

198

GD1AD

NOMESCO Finland

Thorax CT examination

9.1

307.7

612

874

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

30.0

307.7

459

189

J85.1

ICD-10 Finland

Abscess of lung with pneumonia

+∞

307.7

328

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

11.7

307.7

565

622

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

12.0

307.7

410

408

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

10.2

307.7

405

470

J01MA14

ATC

moxifloxacin; systemic

7.2

307.7

667

1233

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

27.3

307.7

265

109

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

5.9

286.3

640

1416

J85.2

ICD-10 Finland

Abscess of lung without pneumonia

+∞

280.0

263

UGC12

NOMESCO Finland

Flexible bronchoscopy

6.1

269.7

558

1145

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

12.2

255.9

268

246

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

5.2

255.7

660

1643

J01FF01

ATC

clindamycin; systemic

4.0

231.3

1086

4197

J86.00

ICD-10 Finland

Empyema with broncho-pleural fistula

+∞

230.1

217

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.9

199.5

1659

9054

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

4.4

187.4

571

1590

GAB10

NOMESCO Finland

Antero- or postero-lateral thoracotomy

33.6

170.1

109

J94.8

ICD-10 Finland

Other specified pleural conditions

11.1

167.6

183

177

J01MA12

ATC

levofloxacin; systemic

3.5

162.9

799

3054

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.2

138.3

792

3274

TGA30

NOMESCO Finland

Thoracocentesis

16.5

128.2

109

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

3.4

120.9

529

1844

ZXD05

NOMESCO Finland

Urgent procedure

2.8

119.0

978

4843

J86.09

ICD-10 Finland

Pyothorax with fistula

+∞

118.8

113

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.3

113.9

515

1826

GAA96

NOMESCO Finland

Other open or percutaneous drainage of pleural cavity

25.8

107.5

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

7.9

106.4

150

201

GAC46

NOMESCO Finland

Partial decortication of pleura

158.6

101.0

106

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

4.1

100.4

309

844

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

15.9

99.5

JN4AD

NOMESCO Finland

Body CT examination

3.1

96.3

483

1807

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

13.2

91.7

WX892

NOMESCO Finland

Monitored bed care

3.5

85.4

337

1085

GAA31

NOMESCO Finland

Thoracoscopy

25.8

83.2

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

3.9

81.4

260

726

GAC96

NOMESCO Finland

Other operation on pleura

276.8

79.0

JN4BD

NOMESCO Finland

Extensive body CT

3.0

78.9

399

1487

TPH04

NOMESCO Finland

Cathetrisation of vein

2.4

78.3

712

3564

R03BB04

ATC

tiotropium bromide; inhalant

2.9

76.8

420

1633

WX408

NOMESCO Finland

General anesthesy, balanced

2.4

75.3

763

3993

R4110

NOMESCO Finland

Physiotherapy

2.3

73.7

805

4344

5100A

ICD-9 Finland

Empyema, With fistula

+∞

71.2

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

3.3

70.6

288

942

TPH07

NOMESCO Finland

Cathetrisation of artery

2.8

70.3

424

1731

C03CA01

ATC

furosemide; systemic

2.2

70.1

984

5852

WX302

NOMESCO Finland

Thoracal epidural anesthesy

3.7

67.6

226

649

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.2

66.1

288

979

J85.3

ICD-10 Finland

Abscess of mediastinum

645.6

64.2

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

6.8

63.2

101

155

N02AA05

ATC

oxycodone; systemic

2.3

61.7

612

3134

Z2446

NOMESCO Finland

Social worker

3.4

59.0

232

739

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

5.4

59.0

120

233

GDC00

NOMESCO Finland

Lobectomy of lung

11.6

58.8

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

3.6

58.7

208

620

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.0

58.1

1265

8660

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.3

56.5

502

2441

WX872

NOMESCO Finland

Intensive care

3.3

56.1

224

720

GAA97

NOMESCO Finland

Other thoracoscopic drainage procedures on pleura

104.4

56.1

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

4.2

55.5

154

386

Z3226

NOMESCO Finland

Physiotherapist

2.3

55.3

518

2574

TGC00

NOMESCO Finland

Bronchial lavation

4.8

55.3

128

278

R06.0

ICD-10 Finland

Dyspnoea

2.0

53.2

768

4511

J94.2

ICD-10 Finland

Haemothorax

15.6

52.9

R81

ICPC

Pneumonia

3.9

52.6

162

438

H02AB06

ATC

prednisolone; systemic

1.9

51.3

1207

8351

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

3.2

51.2

218

728

GAC47

NOMESCO Finland

Endoscopic partial decortication of pleura

83.5

51.1

J47

ICD-10 Finland

Bronchiectasis

5.4

48.6

185

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

5.3

47.9

191

WX730

NOMESCO Finland

Conventional respirator

5.9

47.8

152

ZXE20

NOMESCO Finland

More than three and less than five hours

2.3

47.7

422

2036

A41.9

ICD-10 Finland

Sepsis, unspecified

3.6

47.1

162

472

B18.2

ICD-10 Finland

Chronic viral hepatitis C

8.2

47.0

F10.25

ICD-10 Finland

Alcohol dependence continuous use

5.3

46.4

189

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

8.5

46.4

J94.9

ICD-10 Finland

Pleural condition, unspecified

12.3

46.3

A28

ICPC

Limited function/disability NOS

2.1

46.2

553

3006

XF400

NOMESCO Finland

ECG with 12 standard connections

2.2

45.8

493

2572

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

5.6

45.8

162

Z2221

NOMESCO Finland

Medical doctor

2.0

45.3

672

3945

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.3

45.0

406

1971

J86

ICD-10 Finland

Pyothorax

+∞

44.9

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

3.2

44.7

189

627

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

2.8

44.5

237

896

N05CF01

ATC

zopiclone; oral

1.9

44.0

830

5272

N05BA01

ATC

diazepam; systemic, rectal

2.3

43.7

368

1733

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.2

43.7

413

2042

B01AB05

ATC

enoxaparin; parenteral

1.9

43.7

798

5013

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.2

43.2

181

597

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.1

42.2

492

2638

J93.1

ICD-10 Finland

Other spontaneous pneumothorax

8.3

41.5

N05AA02

ATC

levomepromazine; systemic

3.4

41.0

151

460

GA3AT

NOMESCO Finland

Pleural cytology with ultrasound guidance

15.2

40.9

N05AH02

ATC

clozapine; systemic

5.6

40.8

143

P19

ICPC

Drug abuse

11.2

40.7

ZXE10

NOMESCO Finland

More than one and less than three hours

1.8

40.7

891

5895

Z3231

NOMESCO Finland

Registered nurse

1.9

40.6

699

4286

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

4.6

40.6

220

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

3.0

40.4

185

643

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.0

40.3

522

2903

ZXE00

NOMESCO Finland

One hour or less

1.8

40.2

921

6172

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.1

39.6

177

606

P15

ICPC

Chronic alcohol abuse

3.8

39.3

125

345

N02AX02

ATC

tramadol; systemic, rectal

1.8

38.6

1090

7741

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

3.2

38.4

160

526

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

6.0

38.0

117

N07BB01

ATC

disulfiram; oral

3.2

37.8

153

494

N05AH03

ATC

olanzapine; systemic

2.9

36.9

184

670

N05AH04

ATC

quetiapine; oral

2.1

36.6

434

2330

N03AX16

ATC

[U] pregabalin

1.9

36.0

569

3372

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.8

35.6

192

729

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

35.3

737

4761

J93.9

ICD-10 Finland

Pneumothorax, unspecified

11.0

34.7

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

3.2

34.6

143

467

R04.2

ICD-10 Finland

Haemoptysis

3.2

34.6

140

452

Z51.5

ICD-10 Finland

Palliative care

2.3

34.5

294

1384

JCF12

NOMESCO Finland

Endoscopic insertion of prosthetic tube into oesphagus

8.7

34.1

R03AC02

ATC

salbutamol; inhalant

1.7

33.9

1208

9032

R50.9

ICD-10 Finland

Fever, unspecified

2.0

33.4

424

2326

130

Kela drug reimbursment

Malignant tumour

2.2

33.3

300

1445

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

5.9

33.2

104

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.6

33.0

202

817

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

3.9

32.9

258

J43.9

ICD-10 Finland

Emphysema, unspecified

4.4

32.9

197

D64.9

ICD-10 Finland

Anaemia, unspecified

2.1

32.8

342

1745

ZX120

NOMESCO Finland

Intravenous

2.3

32.7

269

1246

TK800

NOMESCO Finland

Hemodialysis

4.1

32.6

233

J45.9

ICD-10 Finland

Asthma, unspecified

1.9

32.4

463

2644

51399

ICD-8 Finland

Abscess of lung

+∞

32.4

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.3

32.3

124

387

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

3.7

32.3

105

294

GAC00

NOMESCO Finland

Biopsy of pleura

10.8

32.2

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

4.0

32.1

240

J96.1

ICD-10 Finland

Chronic respiratory failure

3.8

32.1

100

272

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.9

32.1

157

565

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.9

32.1

482

2798

P16

ICPC

Acute alcohol abuse

4.8

31.9

153

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.1

31.8

136

453

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

3.0

31.7

144

497

JN3AD

NOMESCO Finland

Abdominal CT examination

2.1

31.7

363

1916

R02

ICPC

Shortness of breath/dyspnoea

2.1

31.7

361

1902

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

3.3

31.4

123

389

F10.24

ICD-10 Finland

Alcohol depence active use

4.8

31.2

152

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

11.1

31.1

WX402

NOMESCO Finland

General anaesthesia

1.9

30.9

526

3173

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.8

30.7

257

J93.8

ICD-10 Finland

Other pneumothorax

10.4

30.7

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.9

30.5

151

547

A02BC02

ATC

pantoprazole; systemic

1.7

30.4

1572

12806

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.8

30.4

154

565

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

5.8

29.9

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.1

29.8

296

1479

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.5

29.6

106

317

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

11.7

29.2

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

10.5

28.9

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

5.0

28.9

130

GAW97

NOMESCO Finland

Other thoracoscopic operation on chest wall, pleura and diaphragm

295.5

28.8

GAC43

NOMESCO Finland

Total decortication of pleura

295.5

28.8

F20.9

ICD-10 Finland

Schizophrenia, unspecified

4.2

28.4

185

J18.1

ICD-10 Finland

Lobar pneumonia, unspecified

5.3

28.2

110

WX882

NOMESCO Finland

High dependency care

3.4

28.1

104

317

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.8

27.7

509

3130

AA1AD

NOMESCO Finland

CT of head and brain

1.7

27.7

753

5167

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

4.8

27.4

132

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

4.3

27.4

173

A06AD11

ATC

lactulose; oral

1.9

27.3

416

2414

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

5.6

27.1

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

4.4

27.0

162

GBB00

NOMESCO Finland

Tracheostomy

4.9

27.0

122

I50.9

ICD-10 Finland

Heart failure, unspecified

1.8

26.9

440

2610

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

5.4

26.9

100

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

3.0

26.7

120

412

S97

ICPC

Chronic ulcer skin

2.3

26.5

205

923

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

5.5

26.2

5130A

ICD-9 Finland

Abscess of lung and mediastinum, Abscess of lung

+∞

26.1

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.1

26.0

260

1299

N06AX11

ATC

mirtazapine; oral

1.6

26.0

757

5270

F10.20

ICD-10 Finland

Alcohol dependence currently independent

3.9

25.5

196

N05CD07

ATC

temazepam; oral

2.0

25.5

329

1804

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

25.4

725

5015

N05BA04

ATC

oxazepam; oral

1.7

25.3

586

3836

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.8

25.3

134

503

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

4.2

25.1

167

SPAT1255

SPAT

Intravenous administration of medicine

2.3

25.0

196

886

R4190

NOMESCO Finland

Nutritional therapy

2.9

24.9

120

428

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

6.0

24.8

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

5.5

24.8

J01XX08

ATC

linezolid; systemic

6.5

24.8

GD5CD

NOMESCO Finland

Thorax and upper abdomen combined very extensive CT examination of

7.8

24.7

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.1

24.6

249

1249

R03AK03

ATC

[U] fenoterol and ipratropium bromide

2.4

24.6

181

797

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

5.3

24.4

A03FA01

ATC

metoclopramide; systemic, rectal

1.7

24.3

491

3090

A03

ICPC

Fever

1.9

24.3

363

2088

N03AG01

ATC

valproic acid; systemic, rectal

2.5

24.1

159

665

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.9

24.0

355

2033

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

4.5

23.9

131

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.6

23.7

225

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

4.9

23.7

108

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

3.4

23.6

250

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

4.6

23.4

125

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.2

23.3

313

JDB10

NOMESCO Finland

Percutaneous gastrostomy

4.8

23.2

110

WX704

NOMESCO Finland

Intubation

2.2

23.2

206

982

WX250

NOMESCO Finland

Intercostal blockade

24.9

23.1

R95

ICPC

Chron obstructive pulmonary disease

2.9

23.0

110

391

51009

ICD-8 Finland

Empyema, UD

+∞

23.0

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.8

22.9

117

431

N05BA02

ATC

chlordiazepoxide; systemic

3.3

22.6

272

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

5.2

22.4

N07BA03

ATC

varenicline; oral

2.7

22.4

126

488

J15.8

ICD-10 Finland

Other bacterial pneumonia

6.2

22.4

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

5.3

22.2

C07AB07

ATC

bisoprolol; oral

1.5

22.2

1199

9525

J96.0

ICD-10 Finland

Acute respiratory failure

4.1

22.1

152

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.8

22.1

113

416

X59

ICD-10 Finland

Exposure to unspecified factor

1.7

22.1

455

2871

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.6

22.1

212

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.6

21.8

127

501

WW200

NOMESCO Finland

Immunization

3.3

21.7

264

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

21.6

744

5340

TKC20

NOMESCO Finland

Catheterisation of bladder

2.1

21.6

211

1043

GAC40

NOMESCO Finland

Pleurodesis with decortication

116.1

21.6

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.2

21.4

194

931

WX725

NOMESCO Finland

Noninvasive ventilation

2.4

21.2

155

679

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

3.1

21.2

299

J86.01

ICD-10 Finland

Empyema with pleuro-cutaneous fistula

+∞

20.9

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.4

20.9

150

653

WW500

NOMESCO Finland

Blood transfusion

2.7

20.8

118

459

N06AB04

ATC

citalopram; systemic

1.7

20.8

441

2802

SPAT1254

SPAT

Administration of medicine

1.8

20.8

351

2090

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

8.8

20.7

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

4.1

20.6

138

C15.5

ICD-10 Finland

Malignant neoplasm: Lower third of oesophagus

5.3

20.6

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

3.5

20.6

212

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.7

20.5

116

451

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.4

20.4

143

615

K08.3

ICD-10 Finland

Retained dental root

2.1

20.4

217

1108

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

20.4

873

6561

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.5

20.3

127

518

F29

ICD-10 Finland

Unspecified nonorganic psychosis

3.0

20.3

312

N06AB03

ATC

fluoxetine; oral

1.9

20.3

262

1432

S27.1

ICD-10 Finland

Traumatic haemothorax

6.3

20.2

5862

FHL

Decortication (removal of visceral or parietal pleura)

48.5

20.2

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

4.7

19.9

100

UJC12

NOMESCO Finland

Flexible oesophagoscopy

5.3

19.9

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

5.8

19.8

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.0

19.7

241

1292

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.8

19.5

337

2018

WX002

NOMESCO Finland

Sedation and analgesia

1.7

19.4

445

2880

L04AA13

ATC

[U] leflunomide

3.6

19.4

177

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

3.3

19.2

232

K86.3

ICD-10 Finland

Pseudocyst of pancreas

6.7

19.1

R03DA04

ATC

theophylline; systemic, rectal

2.2

19.1

161

750

N05AF03

ATC

chlorprothixene; systemic

3.3

19.1

223

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

5.4

19.0

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.2

19.0

162

759

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

6.2

18.9

GAC01

NOMESCO Finland

Endoscopic biopsy of pleura

14.9

18.9

ZXA00

NOMESCO Finland

Right side

1.6

18.9

605

4248

J01MA02

ATC

ciprofloxacin; systemic

1.5

18.9

914

7017

A41.8

ICD-10 Finland

Other specified sepsis

3.2

18.8

230

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

3.6

18.3

174

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

4.4

18.3

103

K86.1

ICD-10 Finland

Other chronic pancreatitis

4.8

18.2

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.3

18.1

145

661

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

18.1

1503

12802

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

5.8

18.1

N06AA12

ATC

doxepin; systemic

2.4

18.0

132

580

XG410

NOMESCO Finland

Flow-volume spirometry

2.5

17.8

111

452

OAB43, ,

SPAT

0.5

17.8

168

3183

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

3.0

17.7

270

H02AB07

ATC

prednisone; oral

1.8

17.6

308

1847

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

4.7

17.5

C45.0

ICD-10 Finland

Mesothelioma of pleura

7.8

17.4

8070/3-C34.3

ICD-O-3

Squamous cell carcinoma, NOS, of lower lobe, lung

6.8

17.4

L28

ICPC

Limited function/disability (L)

1.6

17.3

447

2976

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.5

17.2

177

RS221, ,

NOMESCO Finland

4.2

17.0

109

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

16.9

326

2009

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

4.8

16.8

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

16.6

803

6120

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

4.0

16.6

120

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.0

16.5

181

933

P01AB01

ATC

metronidazole; oral, rectal

1.5

16.4

767

5803

WX203

NOMESCO Finland

Infraclavicular plexus blockade

3.3

16.4

192

RS220, ,

NOMESCO Finland

4.4

16.4

C03DA01

ATC

spironolactone; oral

1.7

16.3

317

1956

N05AF05

ATC

zuclopenthixol; systemic

5.1

16.2

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.4

16.2

111

473

I50.0

ICD-10 Finland

Congestive heart failure

1.9

16.2

224

1250

J45.1

ICD-10 Finland

Nonallergic asthma

2.1

16.1

166

836

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

4.2

16.0

101

N02BE01

ATC

paracetamol; systemic, rectal

1.6

16.0

1962

17862

K22.3

ICD-10 Finland

Perforation of oesophagus

21.1

16.0

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

16.0

348

2215

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

4.9

15.9

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

4.6

15.9

X57

ICD-10 Finland

Unspecified privation

3.1

15.8

218

R03AC12

ATC

salmeterol; inhalant

2.3

15.7

119

530

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

15.7

272

1626

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.7

15.7

318

K22.2

ICD-10 Finland

Oesophageal obstruction

4.7

15.6

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

2.3

15.6

120

538

A46

ICD-10 Finland

Erysipelas

1.6

15.6

377

2462

GWE00

NOMESCO Finland

Reoperation for deep haemorrhage in thoracic surgery

26.5

15.6

N05BA06

ATC

lorazepam; systemic, sublingual

2.2

15.6

134

630

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

5.6

15.6

R82

ICPC

Pleurisy/pleural effusion

22.2

15.5

JN4CD

NOMESCO Finland

Very extensive body CT

2.4

15.5

104

439

K92.0

ICD-10 Finland

Haematemesis

2.7

15.5

303

J01AA02

ATC

doxycycline; systemic

1.5

15.5

1678

14802

J01DB01

ATC

cefalexin; oral

1.5

15.4

1786

15957

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.7

15.4

315

R53

ICD-10 Finland

Malaise and fatigue

1.5

15.4

534

3792

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.9

15.4

195

1057

ZXA05

NOMESCO Finland

Left side

1.5

15.4

547

3906

SPAT1227

SPAT

Substance abuse rehabilitation

6.7

15.3

R4130

NOMESCO Finland

Speech therapy

2.8

15.3

282

TK810

NOMESCO Finland

Hemofiltration

5.5

15.3

R03BB01

ATC

ipratropium bromide; inhalant

2.3

15.1

121

552

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

3.2

15.1

192

JCA55

NOMESCO Finland

Endoscopic dilatation of oesophagus

4.4

15.0

F10.09

ICD-10 Finland

Alcohol intoxication UNS

3.0

14.9

225

V03AA01, ,

ATC

3.3

14.7

170

S22.4

ICD-10 Finland

Multiple fractures of ribs

2.9

14.6

244

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.0

14.6

159

818

M46.4

ICD-10 Finland

Discitis, unspecified

6.4

14.6

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.5

14.5

366

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.8

14.5

228

1322

P17

ICPC

Tobacco abuse

4.1

14.5

100

ZY010

NOMESCO Finland

Hospital outpatient

2.3

14.4

108

479

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

3.7

14.3

119

Z72.0

ICD-10 Finland

Tobacco use

2.8

14.2

248

B44.1

ICD-10 Finland

Other pulmonary aspergillosis

22.4

14.2

Z72.1

ICD-10 Finland

Alcohol use

3.7

14.1

125

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

3.9

14.1

107

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.8

14.0

261

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

4.8

14.0

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

3.4

14.0

150

N05AX12

ATC

aripiprazole; systemic

2.6

13.9

302

H02AB02

ATC

dexamethasone; systemic

1.7

13.9

250

1507

ED1AA

NOMESCO Finland

Mandibular X-ray examination

5.2

13.9

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

3.4

13.8

151

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.3

13.8

100

437

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

3.8

13.8

113

OAA67, ,

SPAT

0.4

13.8

1714

N05AB01

ATC

dixyrazine; systemic

3.7

13.7

118

W19

ICD-10 Finland

Unspecified fall

1.8

13.7

232

1375

B01AB04

ATC

dalteparin; parenteral

2.2

13.7

118

555

P72

ICPC

Schizophrenia

3.1

13.6

183

SPAT1265

SPAT

Breathalyser

4.3

13.6

N05AX08

ATC

risperidone; systemic

1.8

13.6

207

1189

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.9

13.6

169

910

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

13.6

362

2416

51099, ,

ICD-8 Finland

+∞

13.6

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

3.0

13.5

200

J02AC03

ATC

voriconazole; systemic

11.0

13.5

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.5

13.5

325

A07EC01

ATC

sulfasalazine; oral, rectal

1.9

13.5

166

891

B01AA03

ATC

warfarin; systemic

1.5

13.5

502

3607

GAC20

NOMESCO Finland

Excision or destruction of lesion of pleura

140.8

13.5

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

6.3

13.3

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.9

13.3

213

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

4.3

13.1

JLW98

NOMESCO Finland

Other transluminal endoscopic operation on pancreas

15.1

13.1

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.1

13.1

128

633

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.7

13.1

254

R13

ICD-10 Finland

Dysphagia

1.9

13.0

173

952

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

13.0

751

5856

OAB48, ,

SPAT

0.4

13.0

1605

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

13.1

12.9

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.8

12.9

233

8070/3-C34.1

ICD-O-3

Squamous cell carcinoma, NOS, of upper lobe, lung

5.6

12.9

F05.9

ICD-10 Finland

Delirium, unspecified

2.7

12.9

273

XF600

NOMESCO Finland

Bloodpressure measurement

2.0

12.8

150

792

P29

ICPC

Psychological sympt/compl other

2.1

12.8

127

632

A10AB05

ATC

insulin aspart; parenteral

1.8

12.6

191

1095

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

3.4

12.6

130

R4120

NOMESCO Finland

Occupational therapy

2.0

12.5

146

769

GA4BT

NOMESCO Finland

Cathetrisation of pleural cavity with X-ray guidance

+∞

12.5

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

12.5

557

4138

L04AX01

ATC

azathioprine; systemic

2.3

12.5

412

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

3.2

12.5

151

J01FA06

ATC

roxithromycin; oral

1.4

12.5

791

6260

L01BA01

ATC

methotrexate; systemic

2.5

12.4

302

E87.6

ICD-10 Finland

Hypokalaemia

2.4

12.4

382

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

3.9

12.4

RD210, ,

NOMESCO Finland

3.4

12.3

127

N05AD01

ATC

haloperidol; systemic

2.4

12.3

371

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

10.5

12.2

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.8

12.2

212

J15.1

ICD-10 Finland

Pneumonia due to Pseudomonas

16.0

12.1

B01AB10

ATC

tinzaparin; parenteral

1.7

12.1

238

1471

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.5

12.0

319

A02BC01

ATC

omeprazole; systemic

1.4

12.0

562

4210

Z72.2

ICD-10 Finland

Drug use

10.1

12.0

A01

ICPC

Pain general/multiple sites

1.7

12.0

211

1265

P18

ICPC

Medication abuse

4.9

11.9

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

2.7

11.8

244

N06AX16

ATC

venlafaxine; oral

1.7

11.8

248

1558

R03AL11

ATC

formoterol, glycopyrronium bromide and budesonide; inhalant

4.2

11.8

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.1

11.8

109

528

GDB10

NOMESCO Finland

Wedge resection of lung

14.7

11.8

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.1

11.7

110

536

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.6

11.7

263

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.3

11.7

405

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.4

11.6

331

WF004

NOMESCO Finland

Palliative radiotherapy

2.7

11.5

236

C10AA07

ATC

rosuvastatin; oral

0.7

11.5

418

5689

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

10.1

11.5

J85.0

ICD-10 Finland

Gangrene and necrosis of lung

+∞

11.5

J86.0

ICD-10 Finland

Pyothorax with fistula

+∞

11.5

D64.8

ICD-10 Finland

Other specified anaemias

2.8

11.5

197

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

4.1

11.4

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

3.8

11.3

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

3.5

11.1

111

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.7

11.1

229

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.8

11.1

173

1001

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.3

11.0

357

C10AX09

ATC

ezetimibe; oral

0.6

11.0

168

2788

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.5

11.0

265

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

4.0

11.0

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

3.0

11.0

163

J18.0

ICD-10 Finland

Bronchopneumonia, unspecified

3.1

11.0

142

N18.0

ICD-10 Finland

End-stage renal disease

3.5

11.0

107

E86

ICD-10 Finland

Volume depletion

2.4

11.0

314

P01BA02

ATC

hydroxychloroquine; oral

1.9

11.0

146

804

N03AX12

ATC

[U] gabapentin; oral

1.5

10.9

328

2243

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

3.8

10.9

GWW96

NOMESCO Finland

Other reoperation in thoracic surgery

43.5

10.9

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

3.5

10.9

103

WX600

NOMESCO Finland

Single shot through catheter

3.5

10.9

103

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

3.2

10.8

133

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.6

10.8

244

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.8

10.8

198

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

4.4

10.7

EBA00

NOMESCO Finland

Extraction of tooth

1.4

10.7

742

5924

S18

ICPC

Laceration/cut

1.3

10.7

1009

8446

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

17.9

10.7

A11CC03

ATC

alfacalcidol; systemic

2.5

10.7

269

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

3.4

10.7

114

A07AA02

ATC

nystatin; oral

1.9

10.7

125

660

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.0

10.7

116

597

A04AA01

ATC

ondansetron; systemic, rectal

1.8

10.6

167

968

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

5.3

10.6

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.8

10.6

147

821

J04AB02

ATC

rifampicin; systemic

3.3

10.5

120

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

2.8

10.5

195

ZY000

NOMESCO Finland

Hospital inpatient

3.7

10.5

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

9.2

10.5

F60.9

ICD-10 Finland

Personality disorder, unspecified

4.0

10.5

JN1BD

NOMESCO Finland

Extensive CT examination of upper part of abdomen

4.5

10.5

L04AA01

ATC

[U] ciclosporin

3.6

10.5

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

14.3

10.5

GDA00

NOMESCO Finland

Incision and dranage of lung

+∞

10.4

T74.1

ICD-10 Finland

Physical abuse

3.3

10.4

121

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

10.4

207

1282

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

3.9

10.4

N17.8

ICD-10 Finland

Other acute renal failure

3.1

10.3

137

JAH00

NOMESCO Finland

Laparotomy

2.3

10.3

330

J98.5

ICD-10 Finland

Diseases of mediastinum, not elsewhere classified

10.6

10.3

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

8.8

10.3

J98.1

ICD-10 Finland

Pulmonary collapse

4.4

10.3

S72.0

ICD-10 Finland

Fracture of neck of femur

2.0

10.3

105

529

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.9

10.2

127

684

TGD00

NOMESCO Finland

Needle biopsy of lung

4.7

10.2

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.9

10.2

126

677

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

13.2

10.2

J46

ICD-10 Finland

Status asthmaticus

2.6

10.1

234

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

3.0

10.1

144

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

3.9

10.1

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

10.1

901

7464

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.5

10.0

247

R28

ICPC

Limited function/disability (R)

3.0

10.0

145

N03AE01

ATC

clonazepam; systemic

1.9

10.0

121

647

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.5

10.0

260

WW200, ,

SPAT

0.7

10.0

346

4771

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.9

9.9

131

720

N03AX09

ATC

lamotrigine; oral

2.2

9.9

400

N05BA12

ATC

alprazolam; oral

1.7

9.9

191

1173

D38.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pleura

16.8

9.9

N04AA02

ATC

biperiden; systemic

2.8

9.8

174

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

2.4

9.8

268

FWC00

NOMESCO Finland

Reoperation for deep infection in surgery of heart and major thoracic vessels

26.1

9.8

Z71.8

ICD-10 Finland

Other specified counselling

1.4

9.8

625

4914

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

4.0

9.8

R60.0

ICD-10 Finland

Localized oedema

1.6

9.8

271

1820

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.7

9.8

176

1062

S01.0

ICD-10 Finland

Open wound of scalp

1.7

9.7

201

1258

N06AB10

ATC

escitalopram; oral

1.5

9.7

342

2417

R03BA02

ATC

budesonide; inhalant

1.5

9.7

333

2341

J15.4

ICD-10 Finland

Pneumonia due to other streptococci

55.2

9.6

N03AF01

ATC

carbamazepine; oral, rectal

1.9

9.6

117

626

TJD20

NOMESCO Finland

Change of gastrostomy tube

7.8

9.6

R06AE07

ATC

cetirizine; oral

1.3

9.6

757

6144

L01CA04

ATC

vinorelbine; systemic

3.8

9.6

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

3.9

9.6

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

4.3

9.6

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.5

9.6

241

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

4.6

9.5

A40.0

ICD-10 Finland

Sepsis due to streptococcus, group A

9.1

9.5

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.8

9.5

135

760

R84

ICPC

Malignant neoplasm bronchus/lung

7.2

9.5

N06AB06

ATC

sertraline; oral

1.7

9.5

193

1203

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.0

9.5

503

N05BE01

ATC

buspirone; oral

2.4

9.5

285

N05AC02

ATC

thioridazine; oral

2.8

9.5

172

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

2.8

9.5

172

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

4.1

9.4

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.9

9.4

117

631

R10.0

ICD-10 Finland

Acute abdomen

2.3

9.4

311

R03AC18

ATC

indacaterol; inhalant

3.9

9.4

M01CB01

ATC

sodium aurothiomalate; parenteral

3.6

9.4

GAB96

NOMESCO Finland

Other thoracotomy

+∞

9.4

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.8

9.3

152

891

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

9.3

332

A04

ICPC

Weakness/tiredness general

1.5

9.3

309

2157

A07AA09

ATC

vancomycin; oral

3.0

9.3

130

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

9.3

152

893

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.5

9.2

233

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.6

9.2

192

N02BF02

ATC

pregabalin; oral

1.8

9.2

130

731

NFJ54

NOMESCO Finland

Internal fixation of fracture of upper femur with intramedullary nail

2.7

9.2

175

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.7

9.2

160

957

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

2.4

9.1

259

K70.1

ICD-10 Finland

Alcoholic hepatitis

4.4

9.1

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.8

9.1

130

734

JCA08

NOMESCO Finland

Endoscopic removal of foreign body from oesophagus

8.3

9.1

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

4.0

9.1

S42.0

ICD-10 Finland

Fracture of clavicle

2.3

9.1

310

F61.0

ICD-10 Finland

Mixed personality disorders

3.3

9.0

101

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.2

9.0

369

GDC10

NOMESCO Finland

Bilobectomy of lung

36.8

9.0

WZC30

NOMESCO Finland

Teaching

1.5

9.0

348

2502

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.1

9.0

376

A02BC05

ATC

esomeprazole; systemic

1.3

9.0

786

6464

R03AK08

ATC

formoterol and beclometasone; inhalant

2.0

9.0

451

188

Kela drug reimbursment

Psychosis requiring demanding treatment

3.9

9.0

GDD00

NOMESCO Finland

Pneumonectomy

18.7

8.9

B44.0

ICD-10 Finland

Invasive pulmonary aspergillosis

24.1

8.9

WF049

NOMESCO Finland

Radiotherapy of metastasis

2.1

8.9

432

GDA20

NOMESCO Finland

Excision of lesion of lung

12.6

8.9

GD2CT

NOMESCO Finland

Cytology of the lungs with CT guidance

12.6

8.9

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

6.8

8.8

R05

ICPC

Cough

1.4

8.8

456

3455

IAB10

NOMESCO Finland

Psychiatric consultation concerning substance abuse

10.7

8.8

F15.1

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use

10.7

8.8

EB4VA, ,

NOMESCO Finland

0.6

8.7

117

2016

B03BA03

ATC

hydroxocobalamin; parenteral

1.8

8.7

133

765

ZXD35

NOMESCO Finland

Usual procedure

2.2

8.7

348

N18.8

ICD-10 Finland

Other chronic renal failure

2.3

8.7

290

L88

ICPC

Rheumatoid/seropositive arthritis

2.1

8.7

355

J93

ICD-10 Finland

Pneumothorax

50.2

8.7

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.6

8.6

200

1288

C34.19

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology

4.8

8.6

SPAT1262

SPAT

Handing over of treatment supplies

1.4

8.6

376

2767

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.8

8.6

153

P28

ICPC

Limited function/disability (P)

4.1

8.5

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

8.5

266

1832

J01CF05

ATC

flucloxacillin; systemic

1.7

8.5

151

909

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

3.0

8.4

116

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.7

8.4

253

3600

N03AX18

ATC

lacosamide; systemic

4.5

8.4

F10.03

ICD-10 Finland

Alcohol-related acute intoxication with delirium

4.9

8.4

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

7.9

8.4

GDW97

NOMESCO Finland

Other thoracoscopic operation on lung

+∞

8.3

51010, ,

ICD-8 Finland

+∞

8.3

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

8.3

256

1757

EBA30

NOMESCO Finland

Extraction of root of tooth

1.7

8.3

138

814

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

8.3

264

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.2

8.3

329

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.5

8.3

233

1570

XG466

NOMESCO Finland

Sleep oxymetry

2.1

8.2

356

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

3.2

8.2

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

1.9

8.2

103

558

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

8.2

379

2813

QBC00

NOMESCO Finland

Removal of foreign body from skin of trunk or subcutaneous tissue

14.5

8.2

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.6

8.2

185

1184

N06AA04

ATC

clomipramine; systemic

2.9

8.1

124

R03AL03

ATC

vilanterol and umeclidinium bromide; inhalant

2.8

8.1

141

51899

ICD-8 Finland

Bronchiectasis

11.7

8.1

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

4.0

8.1

J80

ICD-10 Finland

Adult respiratory distress syndrome

6.8

8.1

A10AE04

ATC

insulin glargine; parenteral

1.5

8.1

222

1488

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

6.3

8.0

R03BA05

ATC

fluticasone; inhalant

1.4

8.0

328

2383

J01DA01

ATC

[U] cefalexin

1.3

8.0

1243

10979

N06AA09

ATC

amitriptyline; systemic

1.6

8.0

176

1120

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

2.7

7.9

148

J18

ICD-10 Finland

Pneumonia, organism unspecified

3.4

7.9

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

1.9

7.9

536

QX4YT

NOMESCO Finland

Puncture of superficial collection under ultrasound guidance

7.8

7.9

I50.1

ICD-10 Finland

Left ventricular failure

1.7

7.9

131

774

R01

ICPC

Pain respiratory system

2.8

7.9

132

R18

ICD-10 Finland

Ascites

2.5

7.8

202

A31.0

ICD-10 Finland

Pulmonary mycobacterial infection

8.5

7.8

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

3.4

7.8

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

7.8

144

876

Z3229

NOMESCO Finland

Other healthcare associate professional

1.6

7.8

173

1104

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

3.0

7.7

106

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

3.7

7.7

S72.2

ICD-10 Finland

Subtrochanteric fracture

3.7

7.7

5841

FHL

Trocar rhostomy

45.1

7.7

J15.2

ICD-10 Finland

Pneumonia due to staphylococcus

15.1

7.7

D86.0

ICD-10 Finland

Sarcoidosis of lung

3.1

7.7

101

JCC12

NOMESCO Finland

Thoracoscopic or laparoscopic partial oesophagectomy

6.4

7.7

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

2.2

7.7

273

ZZA00

NOMESCO Finland

Split skin graft

2.1

7.7

339

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

7.7

155

965

L17

ICPC

Foot/toe symptom/complaint

1.3

7.6

577

4627

F19.2

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, dependence syndrome

18.4

7.6

N05AB03

ATC

perphenazine; systemic, rectal

2.1

7.6

334

OAA65, ,

SPAT

0.6

7.6

1693

SPAT1301

SPAT

No procedures

1.3

7.6

601

4853

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

3.2

7.5

RS222, ,

NOMESCO Finland

3.2

7.5

F20.0

ICD-10 Finland

Paranoid schizophrenia

4.1

7.5

XX9XW, ,

NOMESCO Finland

4.1

7.5

F31

ICD-10 Finland

Bipolar affective disorder

3.4

7.5

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

3.8

7.5

SPAT1263

SPAT

Sampling

1.3

7.5

784

6567

N06AX21

ATC

duloxetine; oral

1.5

7.5

203

1355

1240

FHL

Bronchoscopy

2.9

7.5

119

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.6

7.5

178

1154

WX212

NOMESCO Finland

Femoral plexus blockade

2.2

7.5

257

TNX99

NOMESCO Finland

Other orthopaedic minor procedure

2.3

7.5

238

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.1

7.5

316

R05CB01

ATC

acetylcysteine; inhalant, oral

2.6

7.5

153

GAW96

NOMESCO Finland

Other operation on chest wall, pleura and diaphragm

80.3

7.4

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.2

7.4

297

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

1.9

7.4

476

ZYY98

NOMESCO Finland

Missed treatment contact, no notification given by patient

6.5

7.4

E000003, ,

ATC

2.0

7.4

413

J01CA04

ATC

amoxicillin; systemic

1.3

7.4

1662

15305

X99.9

ICD-10 Finland

Assault by sharp object by unknown person

13.4

7.4

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

2.4

7.4

202

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

3.8

7.4

K92.1

ICD-10 Finland

Melaena

1.7

7.3

129

774

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.5

7.3

172

D50.8

ICD-10 Finland

Other iron deficiency anaemias

2.8

7.3

126

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.7

7.3

126

752

J86.02

ICD-10 Finland

Empyema with broncho-pleural-cutaneous fistula

+∞

7.3

5842

FHL

Operative thoracostomy

+∞

7.3

GDB20

NOMESCO Finland

Segmental resection of lung

+∞

7.3

C34.01

ICD-10 Finland

Malignant tumor of the main bronchial epidermoid carcinoma

10.9

7.3

F20.3

ICD-10 Finland

Undifferentiated schizophrenia

6.8

7.3

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.7

7.3

138

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

7.3

563

4528

D10

ICPC

Vomiting

1.9

7.2

430

A99

ICPC

Disease/condition unspecnature/site

1.5

7.2

208

1407

P99

ICPC

Psychological disorders other

2.3

7.2

235

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.9

7.2

480

M05BA04

ATC

alendronic acid; oral

1.6

7.2

147

917

F11.1

ICD-10 Finland

Mental and behavioural disorders due to use of opioids, harmful use

15.8

7.2

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.9

7.2

116

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.1

7.2

307

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.6

7.2

161

1028

R11

ICD-10 Finland

Nausea and vomiting

1.6

7.2

156

989

Y07

ICD-10 Finland

Other maltreatment

3.7

7.2

196

Kela drug reimbursment

Paricalcitol and cinacalcet

4.5

7.2

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.3

7.2

217

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.8

7.2

107

613

GCA12

NOMESCO Finland

Bronchoscopic removal of foreign body

30.1

7.1

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

3.6

7.1

D62

ICD-10 Finland

Acute posthaemorrhagic anaemia

3.1

7.1

GCA32

NOMESCO Finland

Endoscopic insertion of stent into bronch

20.1

7.1

R05

ICD-10 Finland

Cough

1.4

7.1

393

3003

J45

ICD-10 Finland

Asthma

1.6

7.1

170

1104

A16.0

ICD-10 Finland

Tuberculosis of lung, bacteriologically and histologically negative

12.1

7.1

P74

ICPC

Anxiety disorder/anxiety state

2.1

7.1

323

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

7.1

167

1081

EE1AA

NOMESCO Finland

X-ray of upper jaw or palate

6.0

7.1

EBA00, ,

SPAT

2.2

7.0

251

T08

ICPC

Weight loss

2.6

7.0

158

IEY01

NOMESCO Finland

Psychoeducation, individual

4.2

7.0

R07.1

ICD-10 Finland

Chest pain on breathing

2.7

7.0

135

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

2.8

7.0

124

EBA10

NOMESCO Finland

Operative extraction of tooth

1.5

7.0

211

1444

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

6.9

348

2617

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.0

6.9

353

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

3.7

6.9

A10AC01

ATC

insulin (human); parenteral

1.6

6.9

164

1063

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

2.3

6.9

221

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

4.0

6.9

C15.1

ICD-10 Finland

Malignant neoplasm: Thoracic part of oesophagus

13.8

6.9

L04AX03

ATC

methotrexate; systemic

1.6

6.9

170

1112

M54.8

ICD-10 Finland

Other dorsalgia

1.9

6.9

417

J01DA06

ATC

[U] cefuroxime

1.5

6.9

253

1801

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.9

6.8

489

Y04.9

ICD-10 Finland

Assault by bodily force by unknown person

3.5

6.8

OAA80, ,

SPAT

0.5

6.8

1070

J12.1

ICD-10 Finland

Respiratory syncytial virus pneumonia

4.1

6.8

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

2.7

6.8

137

ZXD00

NOMESCO Finland

Emergency procedure

2.0

6.8

328

ENA32

NOMESCO Finland

Incision of deep pharyngeal infection

11.0

6.8

J91

ICD-10 Finland

Pleural effusion in conditions classified elsewhere

11.0

6.8

GBB03

NOMESCO Finland

Percutaneous tracheostomy

40.2

6.8

GAC10

NOMESCO Finland

Removal of foreign body from pleural cavity

40.2

6.8

5CM18, ,

NOMESCO Finland

5.7

6.8

GX2D5

NOMESCO Finland

Sleep oximetry

3.6

6.7

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

2.9

6.7

104

J01GB01

ATC

tobramycin; inhalant, parenteral

16.7

6.7

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.6

6.7

174

1150

R52.0

ICD-10 Finland

Acute pain

2.0

6.7

323

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.7

6.7

119

717

K86.01

ICD-10 Finland

Late effects of pancreatitis caused by alcohol

7.2

6.7

E83.50

ICD-10 Finland

Hypercalcemia

3.0

6.7

K22.7

ICD-10 Finland

Barrett oesophagus

2.6

6.7

150

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

2.0

6.7

344

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

6.7

482

3832

A29

ICPC

General symptom/complaint other

1.4

6.7

269

1947

K85.2

ICD-10 Finland

Alcohol-induced acute pancreatitis

3.7

6.6

8070/3-C15.9

ICD-O-3

Squamous cell carcinoma, NOS, of esophagus, NOS

6.4

6.6

C34.00

ICD-10 Finland

Malignant tumor of the main bronchus without histology

4.0

6.6

WX610

NOMESCO Finland

Patient controlled analgesia

4.0

6.6

RS230, ,

NOMESCO Finland

4.0

6.6

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

2.4

6.6

175

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

3.6

6.6

K65.0

ICD-10 Finland

Acute peritonitis

2.8

6.6

111

A40.8

ICD-10 Finland

Other streptococcal sepsis

2.8

6.6

111

K70.0

ICD-10 Finland

Alcoholic fatty liver

3.3

6.6

T18.1

ICD-10 Finland

Foreign body in oesophagus

3.3

6.6

TGW99

NOMESCO Finland

Other minor procedure in thoracic surgery

8.7

6.5

V03AE02

ATC

sevelamer; oral

4.2

6.5

J42

ICD-10 Finland

Unspecified chronic bronchitis

2.8

6.5

117

S10

ICPC

Boil/carbuncle

1.7

6.5

116

699

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.7

6.5

129

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

2.7

6.5

129

SPAT1240

SPAT

Therapeutic discussion

1.6

6.5

147

943

R5110, ,

SPAT

1.5

6.5

170

1128

S22.3

ICD-10 Finland

Fracture of rib

1.5

6.5

170

1128

D38.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Mediastinum

5.7

6.4

B90.9

ICD-10 Finland

Sequelae of respiratory and unspecified tuberculosis

5.7

6.4

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.5

6.4

147

GAA15

NOMESCO Finland

Insertion of pleural drainage tube by resection of rib

70.0

6.4

GWC00

NOMESCO Finland

Reoperation for deep infection in thoracic surgery

70.0

6.4

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

6.4

485

3878

L02.1

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of neck

3.3

6.4

F11.29

ICD-10 Finland

Addiction caused by opiates UNS

7.4

6.4

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

2.4

6.4

178

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

670

818

11.11

307.65

3.1

2.7

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

486

626

9.55

307.65

1.8

—

(3042936) Bacteria identified in Isolate by Culture

1120

3098

6.05

307.65

3.0

2.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

593

337

23.29

307.65

1.6

1.5

86.58

30.92

g/l

0.58

554

307

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

371

175

25.04

307.65

1.4

1.3

25.97

12.04

u/l

7.51

349

160

(3036782) Glucose [Moles/volume] in Pleural fluid

484

242

25.00

307.65

1.5

1.4

4.51

6.42

mmol/l

15.33

410

231

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

432

468

11.11

307.65

1.4

1.6

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

540

494

13.94

307.65

1.8

1.5

—

(3045788) Cell count panel - Pleural fluid

470

234

24.93

307.65

1.6

1.4

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

295

169

19.85

307.65

1.6

1.4

11.55

13.99

u/l

3.51

286

160

(3028308) Erythrocytes [#/volume] in Pleural fluid

469

254

22.88

307.65

1.6

1.4

48550.13

63679.00

e6/l

0.34

255

149

(3035880) pH of Pleural fluid

310

122

29.17

307.65

1.4

1.3

7.24

7.43

11.28

198

(40768806) Pleura Pathology biopsy report

427

260

19.90

307.65

1.6

—

(3023199) Leukocytes [#/volume] in Pleural fluid

526

293

22.91

307.65

1.6

1.4

17495.76

1433.35

e6/l

4.82

338

209

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

464

226

25.41

307.65

1.4

1.3

1663.67

297.81

u/l

7.76

422

219

(3023368) Bacteria identified in Blood by Culture

1502

6376

4.84

299.04

8.0

4.6

—

(3020630) Protein [Mass/volume] in Serum or Plasma

665

1964

4.34

203.28

2.7

2.8

61.67

66.46

g/l

35.13

634

1816

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

979

3793

3.73

202.44

2.6

2.0

—

(3023383) Lactate [Moles/volume] in Pleural fluid

143

21.40

189.03

1.5

1.3

6.72

3.28

mmol/l

7.28

125

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

773

2682

3.82

186.36

2.6

1.9

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

803

2862

3.76

185.91

2.5

1.9

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

762

2733

3.66

173.06

3.6

4.4

228.39

248.32

u/l

3.15

741

2594

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

203

239

9.21

160.91

4.3

3.7

—

(3023419) Bacteria identified in Sputum by Culture

227

317

7.83

156.21

3.6

2.4

—

(3000494) Fungus identified in Specimen by Culture

687

2446

3.57

155.75

2.1

1.5

—

(3019977) pH of Arterial blood

719

2758

3.33

143.15

14.3

8.4

7.42

7.41

0.18

387

1550

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

717

2766

3.30

141.16

14.3

8.4

5.31

5.11

kpa

5.06

692

2658

(3027801) Oxygen [Partial pressure] in Arterial blood

717

2767

3.30

141.06

14.2

8.4

10.85

11.93

kpa

8.69

692

2658

(3003396) Base excess in Arterial blood by calculation

712

2745

3.30

140.19

14.2

8.3

1.76

0.89

mmol/l

5.57

635

2259

(3012095) Magnesium [Moles/volume] in Serum or Plasma

847

3646

3.08

137.65

5.8

3.6

0.79

0.82

mmol/l

5.40

811

3451

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

382

1038

4.21

126.30

2.8

1.9

1.96

2.30

ug/l

0.20

353

915

(42870588) Differential panel, method unspecified - Blood

1258

6924

2.78

126.13

10.6

6.5

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

124

103

12.66

125.05

1.6

1.4

37.23

68.42

9.74

105

(3014111) Lactate [Moles/volume] in Serum or Plasma

585

2139

3.32

123.99

13.3

8.2

1.30

1.40

mmol/l

1.51

575

2099

(3042631) Mycobacterium sp identified in Specimen

202

332

6.57

119.04

3.3

2.7

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

104

14.67

114.79

1.3

199.77

52.47

ug/l

1.05

(3019069) Monocytes/Leukocytes in Blood

1506

9354

2.73

114.46

11.7

6.8

9.05

9.14

0.45

1478

8784

(3041918) Cholesterol [Moles/volume] in Pleural fluid

20.29

114.38

1.5

1.1

1.62

1.52

mmol/l

0.18

(3016502) Oxygen saturation in Arterial blood

626

2505

3.05

112.57

15.4

8.6

94.52

95.44

2.21

607

2419

(3006504) Eosinophils/Leukocytes in Blood

1499

9340

2.71

112.30

11.6

6.7

2.55

2.88

6.69

1471

8764

(3001604) Monocytes [#/volume] in Blood

1575

10083

2.75

111.24

11.1

6.4

0.72

0.61

e9/l

31.81

1381

8597

(3003458) Phosphate [Moles/volume] in Serum or Plasma

701

3003

2.91

111.23

9.3

6.5

1.07

1.03

mmol/l

2.01

676

2800

(3002030) Lymphocytes/Leukocytes in Blood

1514

9520

2.70

110.63

11.6

6.7

21.14

26.66

65.69

1487

9035

(3006315) Basophils [#/volume] in Blood

1575

10112

2.73

110.08

11.1

6.4

0.04

e9/l

1.47

1384

8626

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

239

496

5.26

109.93

1.6

1.5

—

(3018010) Neutrophils/Leukocytes in Blood

1491

9339

2.67

109.24

11.2

6.6

63.40

57.96

51.29

1467

8933

(3022096) Basophils/Leukocytes in Blood

1490

9334

2.66

109.06

11.8

6.8

0.56

0.66

11.41

1463

8760

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1633

10723

2.76

108.22

10.6

7.0

10.31

12.49

umol/l

14.43

1595

10265

(3019198) Lymphocytes [#/volume] in Blood

1588

10294

2.72

107.82

11.4

6.5

1.73

1.90

e9/l

3.36

1411

9005

(3013115) Eosinophils [#/volume] in Blood

1597

10403

2.71

106.97

12.2

6.7

0.20

e9/l

0.45

1422

9031

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

455

1549

3.41

106.95

2.1

1.7

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

581

2309

3.02

104.95

16.3

9.2

115.23

122.26

g/l

13.02

570

2251

(46235355) HIV 1 and 2 tests - Meaningful Use set

656

2790

2.88

104.66

2.0

1.7

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

103

12.20

101.89

1.7

1.5

2.48

1.98

0.22

(3020779) Urea [Moles/volume] in Serum or Plasma

558

2209

3.01

101.11

9.6

7.6

10.74

10.56

mmol/l

0.20

541

2114

(3026051) Granulocytes/Leukocytes in Pleural fluid

16.30

99.58

1.6

1.3

47.62

25.50

3.38

(3000919) Neutrophils/Leukocytes in Pleural fluid

12.45

97.31

1.5

1.4

53.06

22.16

8.99

(3013650) Neutrophils [#/volume] in Blood by Automated count

1653

11226

2.64

96.86

18.5

9.8

5.36

4.27

e9/l

34.25

1485

9697

(3042010) Triglyceride [Moles/volume] in Pleural fluid

17.90

95.82

1.6

1.1

0.51

2.34

mmol/l

0.76

(3000991) Gas panel - Venous blood

523

2076

2.96

93.61

16.0

9.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

204

426

5.15

92.84

1.7

1.5

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

1427

9225

2.42

90.19

8.7

5.5

30.97

35.16

g/l

83.05

1376

8650

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

20.29

89.84

1.6

1.2

43.88

21.33

u/l

0.76

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

408

1436

3.23

89.76

16.1

10.4

24.89

24.19

mmol/l

3.13

398

1408

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

239

587

4.42

89.18

1.8

1.7

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

130

184

7.42

87.74

1.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

238

596

4.33

86.53

1.7

—

(3032080) INR in Blood by Coagulation assay

1509

10155

2.39

84.62

18.8

17.8

1.30

1.31

inr

0.60

1266

8555

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1422

9338

2.35

84.29

15.2

7.3

1.19

1.20

mmol/l

16.56

1372

8617

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

195

430

4.86

83.08

1.7

1.5

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

281

818

3.77

82.86

4.0

2.8

0.30

0.33

iu/ml

0.75

137

449

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

175

358

5.21

81.37

1.8

1.5

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

158

302

5.54

79.22

1.3

1.1

—

(3033658) Prothrombin time (PT) actual/Normal

922

5182

2.29

77.37

8.6

4.5

83.33

85.27

1.74

908

5093

(3002032) Base excess in Venous blood by calculation

530

2338

2.64

75.91

5.8

3.9

1.86

1.85

mmol/l

0.02

465

1999

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

404

1550

2.94

75.64

16.5

9.4

25.85

24.77

mmol/l

5.88

398

1541

(3021447) Carbon dioxide [Partial pressure] in Venous blood

540

2408

2.62

75.63

5.9

3.8

5.90

5.82

kpa

0.79

520

2339

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1499

10330

2.27

75.41

15.1

8.0

1.19

1.21

mmol/l

14.05

1352

8877

(3012544) pH of Venous blood

542

2445

2.59

73.95

6.0

3.9

7.38

0.08

316

1431

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

374

1391

3.01

73.94

15.7

11.1

15.03

16.05

9.45

361

1340

(3018677) aPTT in Platelet poor plasma by Coagulation assay

685

3450

2.40

73.55

3.0

2.1

30.79

29.88

3.20

670

3355

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

157

338

4.91

68.64

8.9

6.3

12.20

12.11

mg/l

0.09

146

318

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

19.04

68.41

1.7

1.3

50.68

72.07

1.96

(3018418) pH of Serum or Plasma

1016

6162

2.15

68.40

7.4

4.5

7.40

2.57

781

4498

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

365

1414

2.88

66.61

2.3

1.7

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

473

2093

2.58

66.48

2.6

2.3

0.19

0.21

g/l

5.90

436

1951

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

143

295

5.10

65.69

1.8

1.7

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

639

3275

2.31

64.68

3.6

2.8

18.88

22.90

10.39

600

3069

(3004789) Transferrin [Mass/volume] in Serum or Plasma

670

3505

2.28

64.58

3.6

2.7

2.09

2.25

g/l

9.37

631

3257

(3022948) Iron [Moles/volume] in Serum or Plasma

700

3729

2.26

64.57

3.6

2.7

9.60

12.77

umol/l

28.97

661

3489

(3007853) Bacteria identified in Skin by Aerobe culture

515

2458

2.41

60.97

2.3

1.8

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

919

5548

2.09

60.77

2.8

2.3

2.97

2.89

mg/l

0.45

810

4780

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

352

1404

2.78

60.46

6.0

4.0

24.31

24.15

mmol/l

0.35

346

1387

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

163

408

4.22

58.88

1.9

1.8

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

744

4226

2.12

57.14

5.4

4.2

483.71

687.08

ng/l

0.35

641

3513

(1616796) Gas panel - Central venous blood

189

538

3.74

57.04

6.4

4.0

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1620

12167

2.10

56.79

12.2

5.6

6.98

6.85

mmol/l

1.53

1590

11663

(3044640) Blood type and Crossmatch panel - Blood

1025

6566

2.00

56.37

4.2

2.6

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1032

6645

2.00

55.74

4.8

3.4

58.68

38.23

u/l

0.68

981

6276

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1013

6489

1.99

55.45

3.9

2.8

61.17

73.04

u/l

0.41

973

6035

(3021589) Normoblasts [#/volume] in Blood

1256

8676

1.97

55.10

22.3

12.3

0.00

e9/l

0.22

1003

7079

(3027945) Reticulocytes/Erythrocytes in Blood

545

2777

2.26

54.76

3.1

2.7

2.00

1.79

2.85

502

2493

(3024354) Oxygen [Partial pressure] in Venous blood

432

2004

2.42

53.89

5.2

3.2

4.79

4.56

kpa

1.25

418

1943

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

294

1132

2.83

53.69

1.6

1.8

1.80

1.51

g/l

4.25

254

984

(3002582) Erythrocytes [#/volume] in Urine

1064

6996

1.96

53.39

4.3

3.6

55.75

86.83

e6/l

1.04

809

5498

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

119

7.02

52.71

4.1

3.7

—

(3030467) Casts [#/volume] in Urine by Automated count

945

5996

1.97

52.36

4.0

3.5

0.48

0.45

e6/l

0.17

699

4544

(3014891) Appearance of Pleural fluid

13.08

52.08

1.8

1.5

—

(44786800) Granulocytes/Leukocytes in Body fluid

16.00

51.26

1.6

1.5

48.20

17.35

3.08

(3008152) Bicarbonate [Moles/volume] in Arterial blood

345

1475

2.57

51.11

14.3

7.2

25.38

24.49

mmol/l

3.32

331

1409

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

12.49

49.65

1.7

1.6

5.35

7.83

0.46

(3005719) IgG [Mass/volume] in Serum or Plasma

361

1601

2.49

49.39

3.3

2.9

10.58

10.75

g/l

0.29

339

1478

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

159

450

3.72

48.28

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

159

450

3.72

48.28

1.5

1.3

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

194

5.29

48.12

1.6

1.7

—

(40758558) Short blood count panel - Blood

920

5911

1.92

48.04

11.7

6.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

176

541

3.44

47.15

3.4

2.2

120.65

129.67

g/l

4.59

133

425

(3026782) Osmolality of Urine

705

4184

1.98

46.20

3.2

3.0

512.52

547.81

mosm/kgh2o

4.38

628

3695

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

14.24

45.97

1.0

1.2

20.15

24.32

u/l

0.29

(3009445) Proteinase 3 Ab [Units/volume] in Serum

238

899

2.84

44.77

1.6

1.5

17.27

21.18

iu/ml

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

125

315

4.14

44.64

2.0

1.7

—

(44806118) Parainfluenza type 4 nucleic acid detection

119

297

4.17

43.04

1.4

1.6

—

(44790048) Parainfluenza type 2 nucleic acid detection

119

297

4.17

43.04

1.4

1.6

—

(44790047) Parainfluenza type 1 nucleic acid detection

119

297

4.17

43.04

1.4

1.6

—

(44790049) Parainfluenza type 3 nucleic acid detection

119

297

4.17

43.04

1.4

1.6

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

344

1590

2.37

42.57

6.6

4.0

5.16

5.13

kpa

0.19

328

1522

(3018095) Leukocytes [#/volume] in Urine

1105

7730

1.82

42.51

5.3

4.1

90.25

103.68

e6/l

0.28

822

5707

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

796

5036

1.88

42.33

4.0

2.6

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

280

1181

2.56

42.28

1.7

1.5

—

(3028026) IgM [Mass/volume] in Serum or Plasma

293

1263

2.51

42.26

2.3

1.9

1.41

1.39

g/l

0.04

269

1163

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

456

2383

2.14

41.81

3.4

3.0

7.82

9.12

umol/l

0.63

391

2137

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

138

5.74

41.21

2.1

1.5

—

(3009343) pH of Capillary blood

334

1545

2.36

41.18

6.6

4.0

7.42

0.13

294

1295

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

305

1359

2.43

40.89

6.1

3.8

2.36

1.82

mmol/l

1.45

227

994

(3036481) Cortisol [Moles/volume] in Serum or Plasma

372

1809

2.26

40.75

2.7

2.3

390.39

377.78

nmol/l

0.45

353

1677

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

134

5.75

40.27

2.1

1.5

—

(3023183) Ammonium ion [Moles/volume] in Plasma

165

539

3.22

39.99

3.2

2.9

38.42

35.57

umol/l

0.22

151

484

(3015235) Bicarbonate [Moles/volume] in Capillary blood

221

851

2.76

39.96

4.8

3.1

25.14

24.78

mmol/l

0.58

216

840

(3023520) Reticulocytes [#/volume] in Blood

418

2153

2.15

39.60

3.0

2.8

74.08

68.97

e9/l

1.43

287

1602

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

152

5.35

39.17

2.1

1.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1253

9246

1.77

38.96

4.3

2.9

—

estimate

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1824

15088

1.97

38.81

15.5

8.6

89.64

81.29

u/l

10.28

1797

14373

(3037692) Legionella sp identified in Specimen by Organism specific culture

7.55

37.81

1.3

1.7

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

383

1940

2.17

37.73

3.9

2.6

39.45

39.30

u/l

0.01

336

1647

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

685

4256

1.86

37.72

2.4

1.7

1.69

1.40

mg/l

1.37

596

3329

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

212

835

2.69

36.61

2.9

2.2

550.30

534.67

ug/l

0.03

206

796

(3026008) Bacteria identified in Urine by Culture

843

5649

1.77

35.74

3.9

3.3

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1585

12682

1.79

35.67

6.3

4.7

4156.40

1191.59

e6/l

0.33

212

(40767503) Oxygen content in Capillary blood by calculation

150

499

3.14

35.22

4.3

2.6

15.18

16.29

3.95

145

488

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

420

2259

2.05

35.12

3.2

4.3

7.69

27.96

ug/l

2.86

361

1881

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

196

759

2.73

34.96

1.4

1.3

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

972

6824

1.73

34.68

4.9

3.6

2.33

2.35

mmol/l

3.53

913

6189

(3037756) Immunofixation for Serum or Plasma

148

495

3.13

34.43

1.6

1.7

—

(4062490) Immunoglobulin typing, IgG

191

4.53

34.25

1.3

1.2

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

573

3468

1.87

33.69

3.8

3.3

2.90

1.41

e6/l

2.41

247

1790

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

172

635

2.85

33.57

4.1

2.6

4.10

3.63

g/l

2.39

167

606

(3004119) Hemoglobin [Mass/volume] in Venous blood

303

1465

2.23

33.28

5.5

3.2

120.03

129.02

g/l

8.04

292

1421

(3028192) IgG subclass 2 [Mass/volume] in Serum

192

4.45

33.12

1.4

1.2

2.89

2.94

g/l

0.07

138

(3027135) IgG subclass 1 [Mass/volume] in Serum

192

4.45

33.12

1.4

1.2

7.35

7.10

g/l

0.15

138

(3024139) IgG subclass 3 [Mass/volume] in Serum

192

4.45

33.12

1.4

1.2

0.38

0.42

g/l

0.46

137

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

602

3751

1.82

31.98

3.6

3.2

1.28

0.96

e6/l

1.04

274

2084

(3002179) Metamyelocytes/Leukocytes in Blood

346

1802

2.08

31.31

5.5

4.4

0.88

0.72

0.50

196

595

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

405

2234

1.98

31.25

5.8

3.7

—

(3017181) Myelocytes/Leukocytes in Blood

358

1891

2.06

31.18

5.8

4.5

1.00

0.93

0.26

208

635

(3003181) Sodium [Moles/volume] in Urine

123

391

3.27

31.12

1.6

1.3

54.67

63.53

mmol/l

1.53

315

(3000850) Epithelial cells [#/volume] in Urine

742

4945

1.74

31.12

3.3

2.8

5.67

4.39

e6/l

2.12

689

4548

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

187

4.34

30.62

2.2

1.6

—

(3012501) Base excess in Blood by calculation

140

487

2.99

30.41

8.6

4.8

2.99

2.60

mmol/l

0.78

117

326

(3013290) Carbon dioxide [Partial pressure] in Blood

140

488

2.99

30.29

8.6

4.8

5.31

5.01

kpa

2.89

134

480

(3027315) Oxygen [Partial pressure] in Blood

140

488

2.99

30.29

8.6

4.9

8.30

8.42

kpa

0.30

134

479

(3024928) Oxygen saturation in Venous blood

160

607

2.76

29.62

5.0

3.0

61.60

61.33

0.05

152

591

(3034860) Kappa light chains.free [Mass/volume] in Serum

193

815

2.49

28.76

3.7

3.8

294.88

57.44

mg/l

0.56

164

688

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

192

814

2.48

28.36

3.7

3.8

99.61

64.10

mg/l

0.26

163

687

(3028707) Methadone [Presence] in Urine by Screen method

216

3.95

28.36

6.0

2.8

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

10.13

28.30

1.4

1.1

49.83

48.19

mg/l

0.04

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

409

2335

1.91

28.29

2.0

1.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

271

1339

2.16

27.99

1.6

1.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

363

2004

1.96

27.70

2.0

1.6

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

177

732

2.53

27.55

3.7

7.06

3.00

ratio

0.50

108

431

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

147

557

2.75

27.26

1.4

—

(4035726) Immunohistochemistry procedure

320

1709

2.01

26.79

1.5

1.4

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

254

1252

2.16

26.34

5.6

2.8

1.41

1.22

2.20

254

1244

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

335

1831

1.97

26.22

3.9

3.1

307.44

222.85

ng/l

1.42

310

1684

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

137

515

2.76

25.79

1.9

2.1

12.67

11.74

mg/l

0.48

132

474

(3024980) IgG subclass 4 [Mass/volume] in Serum

102

326

3.23

25.59

1.5

1.6

0.75

0.88

g/l

0.51

258

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

610

4033

1.70

25.42

4.0

3.2

2.49

2.45

mmol/l

10.48

551

3613

(3021440) Promyelocytes/Leukocytes in Blood

326

1795

1.95

24.90

6.0

4.6

0.13

0.12

0.08

175

543

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

247

1230

2.13

24.90

5.6

2.8

0.63

0.62

0.21

247

1223

(3047181) Lactate [Moles/volume] in Blood

165

693

2.49

24.83

10.9

6.6

1.24

1.37

mmol/l

0.96

138

609

(3004588) Protein electrophoresis panel - Serum or Plasma

301

1615

1.99

24.78

3.0

2.6

—

(3008536) Aspergillus sp Ab [Presence] in Serum

7.08

24.61

2.4

1.7

—

(3011288) Drugs identified in Urine by Screen method Nominal

102

338

3.11

24.10

5.6

2.8

—

(4198724) Urine methamphetamine measurement

6.49

23.93

1.8

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

917

6803

1.57

23.59

4.3

3.3

2055.33

1588.89

ng/l

2.20

845

5924

(3019309) Folate [Moles/volume] in Red Blood Cells

567

3743

1.68

23.48

2.1

1.8

1199.74

1162.45

nmol/l

0.40

457

2849

(3020191) Ethanol [Moles/volume] in Serum or Plasma

169

3.99

23.09

2.9

1.4

1.31

1.09

promille

0.48

133

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

143

4.28

23.09

1.7

1.2

2.46

1.55

u/ml

0.29

(3021960) Folate [Moles/volume] in Serum or Plasma

830

6057

1.58

22.71

2.1

1.8

18.52

19.63

nmol/l

1.50

762

5142

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

160

693

2.41

22.50

1.4

1.3

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1112

8684

1.54

22.33

4.3

3.1

195.60

157.50

ug/l

3.09

1049

8038

(3025159) Blasts/Leukocytes in Blood

318

1801

1.89

22.18

6.2

4.8

0.01

0.11

2.97

162

504

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

181

843

2.24

21.51

2.0

1.9

36.94

38.69

u/l

0.67

159

741

(3036489) Thrombin time

169

765

2.30

21.49

3.3

2.2

21.09

21.28

0.16

159

695

(3005322) IgE [Units/volume] in Serum or Plasma

228

1165

2.06

21.38

1.5

1.3

377.81

242.98

u/ml

0.43

215

1075

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

120

468

2.65

21.03

6.5

201.04

604.13

iu/ml

0.79

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

877

6569

1.54

20.92

3.0

2.3

210.68

247.97

u/l

0.63

844

6236

(3018572) Chloride [Moles/volume] in Blood

124

493

2.60

20.91

12.4

7.6

104.74

105.38

mmol/l

0.82

111

438

(3039000) Anion gap in Blood by calculation

124

493

2.60

20.91

12.4

7.6

10.59

11.38

mmol/l

1.73

111

438

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

195

948

2.15

20.83

2.7

2.4

4.07

3.75

g/l

1.24

183

867

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

195

949

2.15

20.77

2.7

2.4

7.95

7.32

g/l

4.21

183

867

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

195

949

2.15

20.77

2.7

2.4

4.11

4.15

g/l

0.28

183

869

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

132

543

2.52

20.75

1.9

1.5

0.24

g/l

0.16

123

521

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

183

3.68

20.66

1.2

1.4

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

134

4.18

20.58

1.8

2.4

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

210

1066

2.07

20.02

9.7

5.4

1.75

1.65

0.70

197

1003

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

175

828

2.20

20.00

2.8

2.5

10.22

10.62

g/l

0.47

163

741

(3037522) Nuclear Ab [Titer] in Serum

403

2522

1.72

20.00

1.5

1.3

451.43

455.44

titre

0.02

539

(3007930) Methemoglobin/Hemoglobin.total in Blood

196

970

2.11

19.99

10.2

5.7

0.89

0.87

0.44

184

910

(1001926) Buprenorphine [Presence] in Urine by Screen method

106

399

2.74

19.92

5.8

2.1

—

(3011412) CD3 cells [#/volume] in Blood

183

3.63

19.90

1.8

2.4

1056.45

1148.05

e6/l

0.35

163

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

132

560

2.44

19.43

2.1

1.5

1.12

1.19

g/l

1.26

121

536

(3007164) IgA [Mass/volume] in Serum or Plasma

529

3591

1.61

19.08

1.8

1.5

2.95

2.63

g/l

1.87

343

2231

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

182

892

2.13

19.02

2.6

2.5

3.29

2.95

g/l

3.76

170

811

(1761868) Lipid panel - Serum or Plasma

480

6887

0.62

19.01

3.4

3.3

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

206

1060

2.04

18.91

5.1

3.4

25.61

25.16

mmol/l

0.91

199

1016

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

271

1534

1.87

18.79

1.5

—

(3035933) Granulocytes/Leukocytes in Blood

111

446

2.56

18.34

4.2

3.5

60.87

58.89

0.69

111

446

(1175426) CD3 cells/Lymphocytes in Blood

143

3.84

18.08

1.7

2.3

70.67

72.31

0.28

134

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

267

1524

1.85

18.01

5.6

4.3

115.37

97.66

ng/l

1.43

241

1334

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

224

3.19

17.59

1.5

1.9

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

117

494

2.44

17.41

1.3

1.1

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

191

3.36

17.27

1.6

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

191

3.36

17.27

1.6

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

191

3.36

17.27

1.6

1.7

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

112

4.17

17.26

2.1

1.4

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

101

4.32

16.91

1.4

1.1

3.00

4.00

iu/ml

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

241

3.05

16.78

1.4

1.8

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

166

826

2.09

16.66

2.9

2.6

0.55

1.15

g/l

1.79

141

713

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

1621

14143

1.48

16.31

6.6

4.4

24.27

12.54

mm/h

63.12

1563

13203

(3016879) Cocaine [Presence] in Urine

111

474

2.41

16.13

6.4

2.2

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

128

3.81

15.94

1.7

2.7

248.08

234.31

e6/l

0.09

113

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1640

18141

0.67

15.66

5.0

5.2

1.38

1.39

mmol/l

0.15

1504

16778

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

403

2.49

15.46

1.3

1.2

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1115

9132

1.42

15.34

2.7

2.2

88.59

93.69

pmol/l

3.75

710

5076

(3008757) Leukocyte morphology finding [Identifier] in Blood

233

2.98

15.24

3.4

4.4

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

128

3.73

15.16

1.7

2.5

497.00

577.87

e6/l

0.35

106

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

130

614

2.18

14.93

1.5

1.6

1.14

13.20

iu/ml

0.51

103

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

154

777

2.05

14.90

2.2

1.8

—

(3052851) Hemolysis interference index of Serum or Plasma

123

571

2.22

14.74

4.8

3.4

4.37

1.66

index

0.98

311

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

4.48

14.49

1.3

2.3

4896.13

36882.46

u/ml

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

309

2.65

14.36

7.8

5.4

388.58

353.43

umol/l

1.28

279

(3000764) Benzodiazepines [Presence] in Urine

113

515

2.26

14.17

6.3

2.1

—

(3027008) Opiates [Presence] in Urine

113

518

2.24

13.97

6.2

2.1

—

(3015736) pH of Urine

1005

8176

1.40

13.88

4.3

3.4

6.27

6.21

0.81

491

4628

(3028300) Cannabinoids [Presence] in Urine

113

521

2.23

13.78

6.6

2.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

141

710

2.05

13.72

2.7

2.4

0.03

0.02

g/l

0.14

131

635

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1665

18254

0.69

13.62

5.2

5.3

4.28

4.46

mmol/l

9.63

1535

17005

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

160

846

1.96

13.58

2.6

2.0

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

130

638

2.10

13.55

2.7

2.4

0.00

g/l

-0.00

124

600

(40760892) CBC W Ordered Manual Differential panel - Blood

581

4295

1.47

13.53

8.1

4.9

—

(3022313) Gas panel - Capillary blood

193

1091

1.84

13.35

7.7

4.2

—

(3011648) Oxygen content in Venous blood

246

2.77

13.28

2.6

2.5

9.76

11.03

1.44

246

(3027944) Amphetamines [Presence] in Urine

110

512

2.21

13.12

6.7

2.0

—

(40768797) Stomach Pathology biopsy report

396

2722

1.55

13.03

1.5

1.3

—

(3017569) Oxygen content in Arterial blood

133

3.43

12.90

3.7

2.4

15.30

16.44

1.13

133

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1721

0.42

12.84

1.9

2.1

3.49

3.60

ratio

0.27

1395

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

135

689

2.02

12.67

2.7

2.4

0.00

g/l

-0.00

124

601

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

992

8147

1.38

12.52

5.4

4.1

42.31

73.89

ng/l

1.73

818

6194

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

204

2.89

12.46

1.2

1.3

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

370

2.38

12.35

3.1

2.9

242.80

1332.13

u/ml

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1234

10526

1.37

12.15

3.4

2.7

—

(3028433) Virus identified in Specimen by Culture

4.63

12.12

1.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

345

2336

1.56

12.08

2.4

1.9

1.86

1.55

6.64

289

2022

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1583

17410

0.72

12.00

4.5

1.33

1.32

mmol/l

0.36

1438

15962

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1009

8358

1.37

11.87

3.0

2.4

74.27

77.03

nmol/l

2.19

938

7473

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1715

18578

0.71

11.47

5.7

6.1

2.43

2.60

mmol/l

12.08

1572

17223

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

5.16

10.79

1.5

1.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

337

2.33

10.68

1.1

—

(3006245) CD3-CD19+ cells/cells in Blood

4.16

10.61

1.6

2.7

11.26

8.77

0.47

(3040151) Glucose [Moles/volume] in Capillary blood

264

2.50

10.61

4.0

7.7

7.66

7.35

mmol/l

0.26

228

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

294

1985

1.55

10.36

2.7

2.4

7.93

7.62

ug/l

0.11

262

1770

(44816559) Phosphatidylethanol [Mass/volume] in Blood

152

864

1.81

10.34

2.3

1.7

0.41

0.33

mg/l

0.82

428

(3046861) Legionella sp Ag [Presence] in Urine

12.08

10.34

1.1

1.0

—

(4015189) Microbial culture of sputum

4.42

10.26

2.3

1.9

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

109

560

1.99

10.09

1.7

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

470

6139

0.71

10.03

3.0

3.3

0.73

0.78

ug/l

0.60

343

4102

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

140

3.04

9.97

2.3

2.9

37.86

39.06

0.16

(3000570) Elastase.pancreatic [Mass/mass] in Stool

117

619

1.94

9.96

1.5

1.4

203.37

270.37

ug/g

3.34

388

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

162

2.88

9.92

1.2

368.75

129.66

titre

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

106

552

1.96

9.46

1.4

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

184

2.70

9.40

5.1

3.5

15.11

11.56

index

0.60

111

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

675

8257

0.74

9.33

4.1

4.6

21.69

21.99

0.17

322

4144

(3017704) Immunofixation for Urine

136

2.98

9.20

1.3

1.6

—

(3004451) EKG impression Narrative

153

2.84

9.13

1.2

1.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

122

3.07

8.98

2.2

1.9

—

(3021601) Nitrite [Presence] in Urine by Test strip

1169

10155

1.30

8.95

5.0

3.8

0.00

estimate

-0.00

280

2215

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

340

2.18

8.79

1.0

1.1

—

(3008295) Osmolality of Serum or Plasma

239

2.42

8.75

1.3

271.44

279.24

mosm/kgh2o

1.50

176

(3035350) Ketones [Presence] in Urine by Test strip

1180

10282

1.30

8.75

5.1

3.9

5.27

3.68

estimate

0.11

282

2237

(3009261) Glucose [Presence] in Urine by Test strip

1184

10324

1.30

8.72

5.1

3.9

0.03

0.16

estimate

0.44

266

2056

(3000093) Morphology [Interpretation] in Blood Narrative

231

2.41

8.43

1.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

102

3.17

8.23

1.8

2.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

102

3.17

8.23

1.8

2.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

102

3.17

8.23

1.8

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

102

3.17

8.23

1.8

2.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

124

2.93

8.13

2.6

1.9

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

242

1650

1.52

8.12

6.7

4.3

1.21

1.22

mmol/l

1.86

229

1437

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

187

2.54

8.08

1.5

1.2

80.48

66.75

u/l

0.25

163

(3002256) Pathology report gross observation

362

2673

1.42

8.07

1.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

249

2.32

8.02

2.4

2.3

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

1213

0.46

7.95

1.7

1.8

3.09

3.47

mmol/l

1.63

881

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

3.22

7.94

2.3

2.6

213.27

102.88

umol/l

0.75

(4195642) Thrombophilia screening test

257

2.29

7.90

1.3

1.2

—

(21494755) Public health laboratory ask at order entry panel

1430

0.51

7.84

1.3

1.4

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

3.40

7.80

3.0

2.6

0.63

0.61

mmol/l

0.38

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

141

853

1.70

7.78

2.8

3.5

241.15

5135.50

u/ml

0.91

121

749

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

6.97

7.76

1.2

1.0

10.57

16.45

iu/ml

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

6.38

7.70

14.8

12.4

5.94

5.62

mmol/l

0.08

(40768804) Tissue Pathology biopsy report

875

7418

1.29

7.68

2.4

2.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

888

10289

0.78

7.66

5.0

5.7

2.58

3.42

ug/l

0.86

789

9318

(3000012) Reticulocyte production index

374

2.04

7.62

2.5

2.2

1.01

0.89

0.90

270

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

281

2.20

7.59

1.2

1.3

1.67

3.92

u/ml

1.32

101

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

6.17

7.54

1.2

1.1

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

1654

15212

1.30

7.48

53.1

22.0

14.56

13.74

76.25

1643

15009

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

154

967

1.63

7.38

3.6

3.5

4.27

4.47

pmol/l

1.50

138

851

(3000492) Spirometry study

269

1913

1.46

7.33

1.7

1.5

—

(3017732) Neutrophils [#/volume] in Blood

334

2472

1.41

7.32

5.4

3.5

6.40

4.99

e9/l

0.60

294

2128

(40761539) Cells [Type] in Urine sediment by Light microscopy

4.16

7.27

1.2

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

222

2.33

7.26

2.5

2.6

—

(4268621) Lupus anticoagulant assay

199

2.39

7.13

2.1

2.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.45

7.12

4.1

2.9

5.16

4.88

kpa

0.42

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.45

7.12

4.1

2.9

10.45

10.22

kpa

0.16

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

8.80

7.04

1.4

1.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

304

2.10

7.01

1.5

1.3

—

(21494814) CD8 cells/Lymphocytes in Specimen

3.31

6.97

1.7

2.1

30.24

29.80

0.04

(3027456) Digoxin [Moles/volume] in Serum or Plasma

472

1.88

6.96

3.2

3.4

0.86

0.84

nmol/l

0.11

388

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1400

12662

1.27

6.93

5.3

3.4

73.19

55.24

u/l

6.98

1325

11867

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

138

857

1.65

6.92

8.5

4.2

24.57

24.73

mmol/l

0.19

128

793

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1663

17776

0.77

6.91

7.4

6.8

40.61

40.00

mmol/mol

1.60

1548

16590

(3044927) Protein electrophoresis panel - Urine

241

2.23

6.84

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

275

2.14

6.76

1.2

3.07

6.33

u/ml

1.11

123

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

116

694

1.71

6.70

4.6

3.6

1.89

1.63

mg/l

1.86

111

620

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

3.31

6.69

1.5

2.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

3.31

6.69

1.5

2.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

145

2.58

6.62

3.5

2.2

7.41

7.79

mmol/l

0.41

145

(3023487) Leukocytes [#/volume] in Peritoneal fluid

3.12

6.59

1.7

2.2

1115.64

813.99

e6/l

0.24

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1953

18498

1.35

6.42

47.1

18.0

51.06

26.83

mg/l

100.97

1889

15519

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

3.22

6.42

1.6

2.3

—

(3014051) Protein [Presence] in Urine by Test strip

633

5248

1.28

6.38

3.6

3.0

0.13

0.05

—

133

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

6.56

6.33

1.1

1.5

—

(3042517) Benzodiazepines panel - Urine

9.27

6.28

7.8

1.5

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

3.26

6.28

1.1

2.0

30960.00

25112.62

e6/l

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

3.68

6.20

1.2

1.7

—

(40761536) Microorganisms panel - Urine sediment

225

1601

1.45

6.11

5.6

4.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

535

0.31

6.00

1.5

1.6

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

117

2.67

5.99

3.0

3.3

1.27

1.06

0.36

117

(3044007) Cell count panel - Peritoneal fluid

3.21

5.87

1.7

1.9

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

8.04

5.83

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

265

2.06

5.80

1.2

105.02

112.13

0.87

244

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

273

2.04

5.74

1.2

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

567

1.70

5.59

1.6

1.4

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

3.15

5.46

1.3

1.2

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

231

2.10

5.45

1.4

1.5

65.61

60.85

0.33

147

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

106

2.66

5.41

4.4

3.0

858.18

1117.28

u/ml

0.43

106

(3006922) Hepatitis E virus Ab [Presence] in Serum

150

2.35

5.25

1.0

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

172

2417

0.69

5.24

4.3

5.1

32.94

32.04

0.48

118

1580

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

3.06

5.22

2.9

1.7

—

(3026389) Candida sp identified in Specimen by Organism specific culture

223

2.08

5.14

1.3

1.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

108

682

1.61

5.14

1.3

1.2

0.46

0.93

u/ml

—

(3023420) DNA double strand Ab [Units/volume] in Serum

116

747

1.58

5.09

2.0

1.7

11.96

6.39

iu/ml

0.61

177

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

6.90

4.95

1.6

1.3

—

(3052592) Norovirus Ag [Presence] in Stool

4.35

4.93

1.4

1.5

—

(3007566) Smooth muscle Ab [Titer] in Serum

580

1.65

4.92

1.1

1.2

81.11

110.66

titre

—

(3000060) B lymphocytes [#/volume] in Blood

3.50

4.89

1.6

2.5

0.12

0.20

e9/l

—

(3001019) Free T4 and TSH panel - Serum or Plasma

662

0.45

4.86

1.3

1.6

—

(3000475) Leukocytes [#/volume] in Synovial fluid

537

1.66

4.81

1.8

1.6

22588.52

15517.27

e6/l

0.61

370

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

476

1.70

4.80

1.3

1.2

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

3.22

4.61

1.2

1.4

23.48

23.27

g/l

0.02

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

371

1.77

4.53

1.9

1.5

148.87

153.61

au/ml

0.09

112

(3037121) Protein [Mass/volume] in Urine

115

762

1.54

4.49

3.2

3.8

483.01

378.79

mg/l

0.33

354

(3026493) Urate [Moles/volume] in Serum or Plasma

653

5621

1.22

4.48

3.8

3.0

366.52

360.60

umol/l

0.61

581

4939

(3034770) Mitochondria Ab [Titer] in Serum

579

1.61

4.48

1.2

—

1350.00

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

411

1.73

4.43

1.3

178.45

214.81

miu/ml

0.31

170

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

124

2.36

4.41

1.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

471

3922

1.25

4.39

1.3

2.72

1.68

u/ml

0.41

102

1033

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

413

1.72

4.36

1.9

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

119

2.37

4.32

1.4

1.8

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

119

2.37

4.32

1.4

1.8

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

4.50

4.24

1.2

1.6

43.23

48.10

umol/l

0.21

(3034426) Prothrombin time (PT)

3.05

4.24

1.1

1.3

28.88

29.23

0.11

(40768446) Kidney Pathology biopsy report

2.63

4.23

1.6

1.8

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

387

3172

1.26

4.12

1.3

48.46

33.65

iu/ml

0.71

118

958

(3006653) Thiamine [Moles/volume] in Blood

122

2.31

4.11

1.1

1.2

148.32

142.21

nmol/l

0.26

122

(3020876) Protein [Mass/time] in 24 hour Urine

282

1.83

3.98

2.7

2.3

1.72

1.41

g/24h

0.29

167

(36660697) Celiac disease serology panel - Serum

185

1375

1.38

3.98

1.2

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

4.80

3.87

1.2

1.1

102.00

97.35

0.18

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

2.54

3.80

1.2

397.76

202.47

iu/ml

1.03

(3007463) Buprenorphine [Presence] in Urine

12.03

3.76

14.8

2.6

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

108

2.33

3.76

2.1

1.5

6.17

7.10

u/l

0.09

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

616

1.53

3.69

1.6

22.18

22.61

u/ml

0.02

137

(40757373) Influenza virus identified in Isolate

3.01

3.69

1.4

1.8

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1716

17950

0.83

3.64

5.5

5.4

6.19

6.06

mmol/l

2.87

1572

16390

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

8.59

3.26

2.2

1.3

182.83

163.57

ug/g

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

2.81

3.08

1.6

98.36

205.88

nmol/24h

0.40

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

713

7931

0.85

3.06

2.0

1.9

1.45

1.37

mmol/l

0.75

619

6629

(3042111) Morphology [Interpretation] in Bone marrow Narrative

416

1.58

3.06

1.6

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

5.85

3.02

3.1

3.5

107.57

101.08

g/l

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

189

1.86

3.01

1.1

1.0

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

499

4333

1.19

3.00

1.9

1.8

45107881.70

26140580.00

pmol/l

0.25

419

3596

(3043410) Blood group antigens tested for on Red Blood Cells

2.47

2.96

1.4

1.9

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

211

1674

1.29

2.95

4.3

2.9

59.70

64.28

ml/min/173m2

0.76

116

722

(3025941) Bacteria identified in Stool by Culture

129

954

1.37

2.93

1.4

1.3

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

536

0.54

2.92

1.1

0.51

0.66

ratio

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

502

1.51

2.91

1.4

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

2.70

2.89

4.0

6.5

5.03

5.39

kpa

0.63

(3014765) Yersinia sp identified in Stool by Organism specific culture

504

1.50

2.86

1.4

1.1

—

(4094501) Cardiovascular stress test using bicycle ergometer

592

0.57

2.79

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

4.46

2.79

1.5

1.3

—

(3029937) Albumin [Presence] in Urine by Test strip

648

5786

1.17

2.77

5.7

4.0

0.00

estimate

0.96

244

1982

(3003694) ABO and Rh group [Type] in Blood

601

5335

1.17

2.77

1.5

1.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

508

1.49

2.76

1.4

1.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

8.35

2.75

1.0

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

181

1.84

2.74

1.8

1.4

21.22

27.39

0.79

111

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

218

1.76

2.73

1.2

1.4

—

nmol/l

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

3.25

2.72

1.8

1.9

13.67

17.20

umol/l

0.63

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

3.25

2.72

2.3

3.8

39.82

41.24

umol/l

0.10

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

318

1.62

2.70

1.1

1.75

1.52

g/l

2.22

294

(3002619) Bacteria identified in Specimen by Culture

2.80

2.64

1.6

1.2

—

(3004775) Volume in Urine collected for unspecified duration

162

1.86

2.62

2.9

2.2

737.05

627.69

0.60

100

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

579

0.58

2.60

1.1

1.2

1.43

1.48

g/l

0.63

579

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

128

1.96

2.55

1.4

—

(1002224) Polysomnography panel

879

0.66

2.54

1.0

1.1

—

(3036048) Francisella tularensis Ab [Titer] in Serum

2.87

2.54

1.3

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

129

1.95

2.50

1.4

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

263

1.65

2.48

1.2

1.4

0.34

0.38

nmol/l

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

167

1.81

2.41

1.7

1.5

31.50

24.17

u/ml

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

133

1022

1.32

2.40

2.5

2.4

—

(3036525) Urea [Moles/time] in 24 hour Urine

4.13

2.36

3.0

3.9

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

419

1.49

2.35

1.4

1.2

11.94

2.05

u/ml

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

140

1.87

2.32

1.2

—

(3016750) Collection duration of Urine

126

1.91

2.30

2.7

2.0

505.80

486.83

min

0.21

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

607

0.62

2.28

1.6

1.9

4.42

4.96

mg/l

0.14

453

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

2.10

2.22

1.4

1.7

2.92

10.81

nmol/l

0.79

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

5.56

2.21

2.6

5.0

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

521

1.41

2.12

1.4

1.2

21.99

32.16

u/ml

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

381

1.48

2.09

1.5

1.3

329.46

279.75

u/ml

0.61

218

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.91

2.07

1.1

1.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

135

1064

1.29

2.06

1.8

1.7

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.11

2.02

1.8

1.3

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

145

0.34

2.01

1.8

1.5

—

(3011985) Renin [Units/volume] in Plasma

271

1.56

2.01

1.5

1.4

93.20

82.78

mu/l

0.08

244

(3018333) Ribosomal P Ab [Presence] in Serum

126

1.83

1.98

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

291

2504

1.19

1.95

1.5

1.4

—

(3047189) Immunofixation for 24 hour Urine

120

1.84

1.92

1.9

1.8

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.93

1.90

4.2

1.4

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.19

1.88

1.3

1.4

—

(3019150) Specific gravity of Urine by Refractometry

503

4529

1.14

1.86

5.8

4.0

1.02

kg/l

2.22

356

3083

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.65

1.86

1.8

2.3

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

2.09

1.86

1.5

2.8

17.33

128.94

ug/l

0.51

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

100

1.91

1.85

1.1

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

130

1.78

1.81

1.1

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

1960

19130

1.16

1.81

51.0

21.7

138.33

139.67

mmol/l

68.31

1943

18774

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

101

1.89

1.80

2.2

2.4

—

(3042733) HLA Ab [Presence] in Serum

2.06

1.80

7.5

5.0

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

2.06

1.80

1.1

1.3

14.06

13.38

g/l

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

2.06

1.80

1.3

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

203

2404

0.83

1.80

12.9

7.5

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

247

1.55

1.79

1.5

1.4

268.89

321.23

pmol/l

0.54

211

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

131

1.76

1.77

1.1

—

(4281824) Cell count and differential, peritoneal fluid

154

1.70

1.76

1.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

499

1.37

1.73

1.5

1.2

14.14

3.31

u/ml

0.40

(3050794) Legionella sp Ab [Presence] in Serum

2.92

1.72

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

3.85

1.71

1.2

1.4

571.60

379.46

umol/24h

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

250

1.53

1.71

1.2

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

3.16

1.66

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

3.16

1.66

1.0

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

142

1.70

1.64

1.3

1.2

111.71

99.49

pmol/l

0.44

142

(3020393) Adenovirus Ag [Presence] in Stool

3.58

1.61

1.0

1.1

—

(40768443) Skin Pathology biopsy report

110

876

1.27

1.61

1.4

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

576

1.33

1.60

1.5

1.7

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.51

1.59

1.0

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

136

1.70

1.59

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

136

1.70

1.59

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

136

1.70

1.59

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

500

1.35

1.57

1.5

1.2

3.10

4.80

u/ml

0.58

(3038026) Centromere Ab [Units/volume] in Serum

145

1.66

1.54

1.3

1.1

14.35

74.37

u/ml

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.86

1.50

1.0

3.9

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

126

0.40

1.49

1.6

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

1958

19166

1.14

1.48

51.2

21.9

4.00

4.01

mmol/l

0.23

1938

18787

(40768795) Lymph node Pathology biopsy report

178

1.58

1.48

1.4

1.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

124

1.70

1.47

1.3

2.7

11.64

15.53

umol/l

0.18

(3048929) Epstein Barr virus Ab [Presence] in Serum

559

1.32

1.46

1.5

1.3

—

(3020491) Glucose [Moles/volume] in Blood

140

1.65

1.45

4.2

1.8

7.84

6.82

mmol/l

0.81

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

353

1.40

1.44

1.2

1.1

—

1.01

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.13

1.44

1.6

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

456

1.35

1.43

1.9

1.3

39.37

45.11

u/l

0.16

395

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.73

1.43

1.3

1.0

—

(3009508) Creatinine [Moles/volume] in Urine

788

7388

1.10

1.41

4.4

3.6

7.09

7.94

mmol/l

6.01

689

6229

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

178

0.50

1.39

1.0

1.4

198.16

218.08

pmol/l

—

178

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

325

0.61

1.39

2.1

1.5

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.42

1.39

1.9

2.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

800

0.76

1.37

1.1

1.0

—

(40768800) Prostate Pathology biopsy report

675

0.74

1.36

1.3

1.2

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

1.83

1.35

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

367

1.37

1.33

1.5

1.2

28.01

49.03

u/ml

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

550

1.30

1.33

2.6

2.0

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

144

1.60

1.32

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

233

1.47

1.32

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

160

1.57

1.31

1.2

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.78

1.28

4.0

2.6

0.40

0.61

u/field

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.29

1.27

1.9

2.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

203

1.48

1.25

1.9

1.3

271400.40

125671.18

e6/l

0.27

138

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

2.40

1.24

7.3

6.2

102.33

62.45

ug/min

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

100

1.71

1.23

2.3

1.4

20.42

21.81

umol/l

0.07

(3032057) Clostridioides difficile [Presence] in Stool

2.00

1.23

2.1

2.3

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

212

1.47

1.23

3.0

1.3

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

505

1.30

1.21

3.4

3.5

1147.93

946.75

u/ml

0.06

470

(3004716) Salmonella sp identified in Stool by Organism specific culture

738

1.24

1.20

1.5

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.31

1.18

1.2

1.4

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

2.11

1.18

4.3

7.5

11.40

10.52

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

173

1.51

1.18

2.4

2.0

1.19

1.40

u/field

0.18

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

1.16

0.0

3.2

—

43.27

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

0.00

1.16

0.0

6.5

—

9.67

—

(3024869) Neuronal Ab [Presence] in Serum

2.05

1.15

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.50

1.15

1.0

1.3

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.50

1.15

1.0

1.4

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

2.50

1.15

10.4

3.3

1.53

2.60

mg/l

—

(3049717) Cytology report of Urine Cyto stain

119

998

1.20

1.15

2.6

2.7

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.34

1.12

1.0

1.2

—

(37208534) Antinuclear antibody arbitrary concentration in serum

1.90

1.12

1.2

1.0

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

111

1.63

1.12

11.1

7.9

2014.17

55.26

u/ml

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

242

1.41

1.12

1.6

1.4

—

(3045142) Bone marrow Pathology biopsy report

268

1.39

1.10

1.5

1.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

209

1.44

1.10

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.26

1.10

1.0

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.67

1.10

1.0

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

215

2425

0.88

1.10

2.3

2.4

12.51

13.47

nmol/l

0.90

181

2181

(3010813) Leukocytes [#/volume] in Blood

1976

20065

0.90

1.07

62.2

27.0

8.20

6.87

e9/l

32.45

1938

19576

(3000963) Hemoglobin [Mass/volume] in Blood

1976

20064

0.90

1.06

62.7

27.1

123.79

136.20

g/l

172.31

1962

19824

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

113

1.60

1.05

1.1

1.3

—

(3024263) Appearance of Synovial fluid

113

1.60

1.05

2.1

1.5

—

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

1976

20062

0.90

1.05

64.9

27.5

37.53

40.57

108.58

1960

19805

(3026361) Erythrocytes [#/volume] in Blood

1976

20062

0.90

1.05

62.1

26.9

4.18

4.50

e12/l

101.59

1937

19576

(3025130) Human papilloma virus identified in Specimen

129

1.56

1.05

2.7

2.0

—

(3035941) MCH [Entitic mass]

1976

20061

0.90

1.05

61.9

26.8

30.13

30.48

13.06

1960

19815

(3024731) MCV [Entitic mean volume] in Red Blood Cells

1976

20059

0.90

1.04

62.0

26.9

91.60

91.42

0.89

1960

19815

(44806071) Cardiolipin IgM antibody measurement

2.28

1.03

1.0

—

(3041096) Erythrocytes [Presence] in Urine by Automated

577

5405

1.09

1.03

4.9

3.4

0.01

0.03

estimate

0.49

234

1721

(3007461) Platelets [#/volume] in Blood

1976

20057

0.90

1.03

62.3

27.0

274.67

240.22

e9/l

51.33

1940

19641

(3018133) Calcium [Moles/volume] in Urine

2.06

1.03

1.3

2.2

1.74

3.10

mmol/l

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.92

1.02

2.0

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.00

1.00

1.1

1.5

—

7520.00

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

231

1.39

0.99

1.7

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

231

1.39

0.99

1.7

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

240

1.38

0.98

1.6

1.4

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.18

0.98

1.0

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.18

0.98

1.0

83.20

101.57

titre

—

(4212803) Bone marrow aspirate examination

2.18

0.98

1.0

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

232

1.38

0.97

1.7

1.4

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.86

0.96

1.0

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

121

1407

0.85

0.96

1.5

1.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

425

1.28

0.96

1.9

2.86

18.32

iu/l

0.56

165

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

462

1.26

0.94

2.6

2.0

—

(3001186) Copper [Moles/volume] in Serum or Plasma

1.78

0.94

1.0

15.58

16.24

umol/l

0.23

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

323

2959

1.11

0.93

1.3

22.09

11.69

u/ml

1.02

1126

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

1.82

0.92

1.0

1.2

7.66

8.95

pmol/l

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

235

1.37

0.91

1.0

1.1

—

1.98

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

118

1.53

0.90

3.6

1.9

114.94

130.00

ng/l

0.14

118

(3016018) Differential panel - Cerebral spinal fluid

236

1.36

0.89

3.0

1.4

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.91

0.88

1.1

1.7

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

111

1.54

0.87

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.00

0.87

1.0

1.3

—

(3036670) Protein [Mass/volume] in Synovial fluid

1.72

0.86

1.0

1.2

36.50

38.26

g/l

—

(40768441) Liver Pathology biopsy report

145

1.45

0.85

1.6

1.5

—

(21491868) Cryoglobulin [Mass/volume] in Serum

1.63

0.84

1.1

1.2

—

0.06

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.78

0.84

1.0

1.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

274

1.32

0.84

2.1

2.2

5595.43

4412.14

u/l

—

104

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

310

1.30

0.82

1.7

1.6

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

207

1867

1.12

0.82

3.6

2.6

0.67

0.46

e6/l

0.54

201

1798

(3024522) Salmonella sp identified in Specimen by Organism specific culture

241

1.33

0.80

1.7

1.4

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.79

0.0

1.4

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

0.79

0.0

1.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

800

7670

1.07

0.76

5.4

3.9

0.01

0.02

estimate

0.59

249

1851

(44813793) Dust mix specific IgE antibody measurement

107

1.50

0.76

1.1

1.0

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.64

0.73

1.0

—

(3000330) Specific gravity of Urine by Test strip

1000

0.85

0.73

3.7

3.4

1.02

ratio

0.56

918

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

2.00

0.72

1.6

1.5

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

159

1.39

0.72

1.8

1.7

—

(3004616) Nuclear Ab [Presence] in Serum

238

1.31

0.70

1.3

1.2

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1414

13822

1.06

0.68

4.5

3.9

14.92

14.89

pmol/l

0.15

1310

12556

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

127

1.42

0.68

1.1

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

127

1.42

0.68

1.1

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

447

1.21

0.67

2.1

1.7

0.84

0.86

nmol/l

0.09

375

(3010726) Horse dander IgE Ab [Units/volume] in Serum

249

0.72

0.66

1.0

1.1

1.87

1.48

u/ml

—

136

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

532

1.19

0.65

2.9

2.3

418.76

105.61

ug/min

1.43

326

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.62

0.65

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

103

1.46

0.65

1.3

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

199

1.31

0.62

1.2

—

(4034850) Laboratory test

588

0.83

0.62

22.3

11.4

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

425

1.20

0.61

1.1

13.48

9.06

eliau/ml

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

0.08

—

(3027035) Albumin [Mass/time] in 24 hour Urine

0.00

0.59

0.0

1.2

—

652.23

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

131

1453

0.90

0.59

1.7

1.5

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.58

0.0

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

237

1.27

0.58

1.1

1.2

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

1.48

0.57

1.3

1.6

3.70

4.29

umol/l

—

(3023410) Appearance of Cerebral spinal fluid

211

1.28

0.57

3.5

1.6

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

238

1.26

0.56

4.2

3.1

20.27

4.75

nmol/l

0.59

233

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.46

0.56

1.0

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.47

0.54

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

261

0.76

0.53

2.7

2.2

27.50

19.14

mg/l

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.49

0.53

1.3

1.1

—

(3024932) HLA-DR beta [Type]

1.52

0.52

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.39

0.50

1.6

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

1.39

0.50

1.6

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.39

0.50

1.6

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.39

0.50

1.6

1.0

—

(3024471) HLA-A [Type]

1.49

0.49

1.1

1.0

—

(3022621) pH of Urine by Test strip

136

1485

0.91

0.48

3.8

2.6

6.05

0.01

1040

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

120

1.34

0.46

1.1

—

(40765096) Chromosome analysis panel by Banding

0.59

0.45

1.2

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.59

0.45

1.0

1.6

56.18

54.32

ug/l

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

112

1.34

0.44

1.3

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.43

0.42

1.0

1.1

—

(4146454) Self-monitoring of blood glucose

229

0.78

0.42

2.8

2.4

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.38

0.41

1.0

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.52

0.41

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.41

0.0

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.33

0.40

1.0

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

171

0.76

0.39

1.8

1.5

—

(3020650) Glucose [Presence] in Urine

1.37

0.38

1.2

1.5

0.00

0.09

estimate

—

(3012565) Volume of 24 hour Urine

107

1.31

0.37

3.5

2.7

1245.00

1910.52

2.08

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.35

0.37

1.0

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

506

1.13

0.37

1.4

11.15

8.16

u/l

0.67

398

(3005570) Glucose [Moles/volume] in Urine

202

0.79

0.36

1.9

—

(3006270) Folate [Moles/volume] in Blood

168

0.77

0.35

1.2

329.77

355.41

nmol/l

0.19

142

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.64

0.35

1.0

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.43

0.35

1.8

1.2

1.14

1.18

mmol/l

—

(3035285) Chloride [Moles/volume] in Venous blood

254

1.18

0.35

2.7

2.5

103.70

105.56

mmol/l

0.83

249

(3041354) Potassium [Moles/volume] in Venous blood

254

1.18

0.35

2.7

2.5

3.96

4.08

mmol/l

0.57

249

(3023511) Choriogonadotropin [Units/volume] in Urine

126

1.27

0.35

1.6

1.3

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

1.33

0.33

3.8

3.3

—

59.05

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.32

0.33

1.8

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.32

0.33

1.8

1.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

128

1193

1.08

0.33

2.2

1.9

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

307

0.85

0.33

1.0

1.1

3.14

2.25

u/ml

0.18

174

(3033705) Calcium.ionized [Moles/volume] in Venous blood

247

1.18

0.33

2.7

2.5

1.21

1.19

mmol/l

1.53

242

(3006462) Nitrate [Presence] in Urine

1.35

0.32

2.6

3.3

—

(3014271) Vancomycin [Susceptibility]

119

1.26

0.31

3.3

2.8

—

(40768793) Breast Pathology biopsy report

286

1.16

0.31

1.2

1.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

139

1310

1.06

0.28

2.2

1.9

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

479

1.11

0.28

1.9

1.7

409.62

273.12

mu/l

2.25

445

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.25

0.27

1.0

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

258

0.85

0.27

1.0

1.1

4.74

2.15

u/ml

—

120

(3008898) HLA-B27 [Presence]

551

0.91

0.26

1.0

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

141

1.21

0.26

1.8

1.5

81.18

88.44

umol/l

0.46

141

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

1799

17862

1.03

0.25

38.8

17.6

80.08

78.09

ml/min/173m2

2.77

1717

16647

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

287

0.87

0.24

1.4

1.5

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.25

0.24

1.1

—

(3022145) Colonoscopy Study observation

234

2254

1.04

0.23

1.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1939

19492

0.97

0.22

22.0

12.7

26.97

27.41

u/l

0.19

1910

18909

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

11.6

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.1

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

0.21

0.0

1.7

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.4

—

494.45

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.00

0.21

0.0

1.7

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.21

0.0

1.3

—

(3011048) Pyruvate [Moles/volume] in Blood

0.00

0.21

0.0

1.2

—

87.67

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

2.3

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

32.43

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

262

0.88

0.21

1.0

1.1

17.44

4.78

u/ml

0.71

145

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.20

0.0

1.7

—

25.14

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

1.23

0.20

1.8

2.2

11.93

8.76

mg/l

—

(3045424) Erythrocytes [Presence] in Urine

104

987

1.06

0.19

2.4

2.1

0.00

0.89

estimate

0.51

286

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

184

1.14

0.19

1.1

1.2

—

(3048689) Calprotectin [Mass/mass] in Stool

223

2158

1.04

0.19

2.5

202.69

151.45

ug/g

1.05

186

1749

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.13

0.18

1.0

1.3

—

(4024509) Urine culture

888

0.94

0.18

2.6

2.0

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

138

1.16

0.17

6.4

5.6

130.66

40.81

u/ml

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.11

0.17

1.3

1.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.11

0.17

1.0

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

0.76

0.17

1.0

—

5.25

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

0.73

0.17

3.6

1.2

66.68

60.83

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

119

1241

0.96

0.16

2.3

2.5

17.00

19.67

au/ml

—

111

(44806420) Estimation of glomerular filtration rate

187

1.12

0.15

3.0

2.5

—

(4211845) Urine protein measurement

1.21

0.15

2.6

3.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.15

0.15

1.1

1.0

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

1969

19762

0.98

0.15

50.6

23.6

87.97

84.16

umol/l

1.90

1951

19529

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1.10

0.15

2.0

1.6

35.19

40.14

g/l

—

(3002079) Sodium [Moles/time] in 24 hour Urine

1.10

0.15

1.3

1.4

197.22

178.07

mmol/24h

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

139

0.86

0.14

1.1

43.58

43.78

mg/l

0.01

114

(3019225) pH of Specimen

200

1951

1.03

0.12

6.2

4.5

7.37

7.35

0.66

169

1409

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

288

1.08

0.11

1.1

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

292

0.92

0.11

1.1

—

(3012516) Albumin [Mass/volume] in Urine

717

7099

1.01

0.11

4.0

3.6

86.70

49.95

mg/l

2.47

551

4796

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

153

1.11

0.11

1.5

1.4

381.42

295.42

mu/l

0.48

120

(3002523) Influenza virus A Ag [Presence] in Specimen

291

0.93

0.11

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

136

0.88

0.11

1.1

297.58

299.60

mg/l

0.02

117

(3045414) Leukocytes [Presence] in Urine

185

1893

0.98

0.10

2.7

2.1

0.00

0.01

estimate

0.78

382

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

187

0.91

0.10

1.0

—

(4133840) Spirometry

1.09

0.09

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.03

0.08

1.0

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

120

1229

0.98

0.08

1.2

1.3

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.82

0.07

1.2

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.88

0.06

1.0

1.1

—

(21494434) Karyotype in Bone marrow

226

1.06

0.06

1.2

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

453

1.04

0.06

2.5

1.4

59.60

40.30

e6/l

0.25

338

(3051387) C reactive protein [Mass/volume] in Capillary blood

434

1.04

0.06

7.8

3.5

42.27

30.72

mg/l

0.89

299

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

316

1.04

0.05

1.0

1.1

1.40

99.03

iu/ml

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

475

0.97

0.05

1.3

—

(3020682) Albumin/Creatinine [Ratio] in Urine

727

7239

1.01

0.04

4.8

4.3

17.33

9.00

mg/mmol

2.60

533

4733

(3023323) Follitropin [Units/volume] in Serum or Plasma

478

1.03

0.03

1.4

26.89

25.60

iu/l

0.10

390

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

1520

15223

1.00

0.03

55.7

23.0

328.41

332.89

g/l

59.88

1512

15132

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

460

1.02

0.02

2.5

1.5

3171.97

1177.72

e6/l

0.62

356

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1685

16868

1.00

0.02

5.7

4.9

1.96

1.97

mu/l

0.09

1573

15437

(1761482) Bacteria [#/volume] in Urine by Culture

493

1.01

0.01

3.8

4.3

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

225

0.98

0.00

1.5

130.68

286.02

pmol/l

1.01

220

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

129

1.01

0.00

1.1

1.0

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

199

1.01

0.00

3.7

38.30

27.51

u/ml

0.30

194

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

104

0.96

0.00

1.7

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

116

1.03

0.00

1.7

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

993

1.00

0.00

1.2

115.74

137.51

u/ml

0.16

357

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1.03

0.00

1.6

1.5

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.0

—

(4038314) Semen analysis, post vasectomy

0.00

-0.00

0.0

1.3

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

-0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

-0.00

0.0

8.4

—

74.80

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

-0.00

0.0

1.8

—

1.38

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.7

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

0.98

-0.00

1.0

1.1

1839.22

1440.90

miu/ml

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.7

—

2.82

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

0.99

-0.00

1.1

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

-0.00

0.0

1.2

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

-0.00

0.0

3.8

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.01

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.1

—

27.34

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.1

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(3022689) Creatine [Moles/volume] in Urine

0.86

-0.00

2.0

1.3

6.37

8.57

mmol/l

—

(3022670) pH of Venous cord blood

0.00

-0.00

0.0

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint J10_NECROTIC and mortality.

Females

Parameter	HR [95% CI]	p-value
J10_NECROTIC	3.883 [3.25, 4.64]	< 0.001
Birth year	0.991 [0.98, 1.0]	0.033

During the follow-up period (1.1.1998 — 31.12.2019), 1239 out of 3243 females with J10_NECROTIC died.

Males

Parameter	HR [95% CI]	p-value
J10_NECROTIC	3.933 [3.44, 4.5]	< 0.001
Birth year	0.985 [0.98, 0.99]	0.001

During the follow-up period (1.1.1998 — 31.12.2019), 3480 out of 7999 males with J10_NECROTIC died.

Mortality risk

Mortality risk for people of age

years, who have J10_NECROTIC.

N-year risk	Females	Males
1	0.415%	0.674%
5	2.186%	4.328%
10	5.092%	10.557%
15	9.762%	19.553%
20	15.875%	31.206%

Relationships between endpoints

↥

Index endpoint: J10_NECROTIC – Suppurative and necrotic conditions of lower respiratory tract

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Suppurative and necrotic conditions of lower respiratory tract

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints